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The role of matrix metalloproteinases (MMP)-9 and processing condition of 
biodegradable polymer scaffold has been investigated to optimize engineering vascular 
constructs. For a small diameter vascular construct, uniform 10 µm thickness of high 
porous scaffolds were developed using a computer-controlled knife coater and exploiting 
phase transition properties of salts. The comparative study of fast vs. slow degrading 
three-dimensional scaffolds using a fast degrading poly D, L-lactic-glycolic acid co-
polymer (PLGA) and a slow degrading poly e-caprolactone (PCL) indicated that fast 
degradation negatively affects cell viability and migration into the scaffold in vitro and in 
vivo, which is likely due to the fast polymer degradation mediated acidification of the 
local environment. MMP-9 was crucial for collagen remodeling process by smooth 
muscle cells (SMC). MMP-9 deficiency dramatically decreased inflammatory cell 
invasion as well as capillary formation within the scaffolds implanted in vivo. This study 
reports that the angiogenic response developed within the scaffolds in vivo was related to 
the presence of inflammatory response. Combinatorial polymer libraries fabricated from 
blended PLGA and PCL and processed at gradient annealing temperatures were utilized 
to investigate polymeric interactions with SMC. Surface roughness was also found to 
correlate with SMC adhesion. SMC gathering, proliferation, and protein production were 
highest in regions that exhibited increased surface roughness, reduced hardness, and 
decreased crystallinity of the PCL-rich phases.  This study revealed a previously 
unknown processing temperature and blending compositions for two well-known 








World Health Organization projections suggest that coronary artery disease 
(CAD) will remain the largest element of the global disease burden, reflecting the aging 
of the population. Current options for the management of CAD have their limitations, 
thus confirming the appropriateness of continuing the search for improved therapies to 
reverse the disease process and reduce the global burden (Sleight, 2003). 
There are currently two main vascular surgical treatments for CAD: coronary 
artery bypass graft surgery (CABG) and percutaneous transluminal coronary angioplasty 
(PTCA) with or without stenting.  For some patients, PTCA is a less traumatic and less 
expensive alternative to bypass surgery. However, in about 40 percent of patients treated 
by PTCA, the dilated segment of the artery narrows again within six months post-
treatment. They may then require another PTCA or CABG surgery. Bypass grafting 
involves rerouting blood flow from a site proximal to the stenosis to a site distal to the 
ligation through an available vascular conduit. Due to effects of immunogenicity, 
thrombogenicity and compliance mismatch on the graft patency, the majority of bypass 
grafting procedures use autologous internal mammary arteries and/or the greater 
saphenous vein (Bergsma et al, 1998 and Cooley, 1998). Unfortunately, due to donor site 
disease or unavailability in the case of repeat surgery, these grafts are not always 
available. In those situations, other autologous arteries or veins such as the splenic and 
radial arteries or the basilic and cephalic veins (Acar et al, 1993) must be considered. 
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When these alternatives are unavailable, polymeric substitutes have been employed, 
however, anastomotic occlusions may be a problem (Weyand et al, 1999).  Alternative 
approaches initially centered on the use of allografts and xenografts. Allografts consist of 
gluteraldehyde or cryopreserved greater saphenous veins or umbilical veins. 
Unfortunately, these grafts have one-year patency rates lower than 50% (Ochsner et al, 
1984 and Canver, 1995). Studies investigating gluteraldehyde fixed xenografts have 
shown short-term patency rates of less than 20% (Mitchell et al, 1993). This has led to the 
investigation of biodegradable polymers for tissue-engineered substitutes, which can 
synchronize degradation time with the replacement by natural tissue production from 
autologous cells. Creating an autologous tissue construct for a suitable vascular graft has 
been considered as one of the potential ideal compensative methods. Finally, tissue-
engineering applications have begun to create physiological models of human tissue in 
vitro (Griffith, 2002). 
Vascular remodeling, defined as any enduring change in the size and/or 
composition of an adult blood vessel, allows adaptation and repair. Physiological and 
pathological vascular remodeling entails degradation and reorganization of the 
extracellular matrix (ECM) scaffold of the vessel wall, explaining the recent interest in 
the potential participation of specialized enzymes, called matrix metalloproteinases 
(MMPs). Soluble factors, cell-cell, and cell-matrix interactions finely tune MMP 
expression and activation spatially and temporally. The action of MMPs can evade 
normal control and push remodeling over the edge (Galis, 2002). A thorough 
understanding of the control and consequences of MMP actions may provide a new way 
to manipulate vascular remodeling.  
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This short review will first cover the methods for tissue engineering vascular 
equivalents. The second section will discuss the current knowledge regarding the 
application of biodegradable polymers as biomaterials for vascular constructs. The final 
section will review the role of MMPs in vascular biology and especially the process of 
vascular remodeling. 
 
1.2 Tissue Engineered Vascular  Equivalents 
The low patency rates for polymeric or fixed tissues have led to the investigation 
of tissue engineering approaches to provide viable alternatives for graft materials. The 
focus has been on four major areas: a) Decellularization and recellularization of 
xenogenic tissues; b) Rolled sheets of arterial components (i.e. smooth muscle cells 
(SMC), fibroblasts and the cell synthesized extracellular matrix); c) Contracted collagen 
gels; and d) Cell seeding on non-degradable and biodegradable polymer scaffolds. 
Decellularized tissue has been explored using either xenogenic arteries or small 
intestine submucosa. Human saphenous vein SMC have been shown to grow on 
decellularized porcine aortas (Bader et al, 2000 and Teebken et al, 2000). Human SMCs 
took two to three weeks for complete reseeding and were biocompatible, allowing for 
implantation and subsequent remodeling in vivo. Use of the small intestine submucosa 
allows for a plentiful supply of material and provides appropriate mechanical properties 
but depends on the anticoagulation method used to overcome the thrombogenicity of this 
material (Lantz et al, 1993). More work is necessary to determine whether these methods 
will be suitable for long-term treatment. 
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L’Heureux and his coworkers (1998) pioneered the use of rolled sheets of SMCs 
and fibroblasts. Human umbilical vein derived SMCs and human dermal fibroblasts were 
grown to confluence in culture and treated with ascorbic acid to accelerate matrix 
deposition and cross-linking.  The SMC sheet was placed around a tubular mandrel to 
produce the medial layer. Subsequently, the fibroblast sheet was placed around the SMC 
media to form an adventitial layer. After mechanical preconditioning for up to 56 days, 
these vessels showed superior mechanical strength. Endothelium was then seeded into the 
lumen to provide all three-vessel layers. Grafts into the femoral artery of miniature pigs 
showed patency for 28 days. The preliminary results of this study looked promising but 
in view of time efficiency, it took too long to get enough mechanical strength for 
manipulating the construct.  
The use of SMC or fibroblast contracted collagen gels has also been investigated. 
This process involves incubated cells with soluble collagen, allowing the collagen to gel, 
entrapping the cells. Subsequently, the entrapped cells exert traction on the collagen 
causing the gel to compact. Unfortunately, early experiments resulted in insufficient burst 
strength. A novel method showing limited success was to increase the mechanical 
strength by using a high powered magnet to help the initial alignment of the collagen 
(Tranquillo et al, 1996).  A second method investigated the role of integrins, where 
compaction was shown to be dependant on which integrin-binding domains were used 
(Ogle et al, 1999). A third technique involved the glycation of collagen, in effect cross-
linking the collagen and thus increasing strength (Girton et al, 2000). Using mechanical 
stimulation of the cell seeded collagen gel to induce further remodeling (Seliktar et al, 
2000 and 2003) showed enhanced material properties. However, it has been reported that 
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the initial beneficial improvement of mechanical properties was ultimately lost, which 
can be explained by failure of native arteries, where the vascular pathology was 
associated with the inappropriate degradation of the ECM scaffold of the arteries by 
MMPs (Galis, 1999). It was found that mechanical conditioning of SMC-collagen 
constructs results in an overall increase in MMP production, and an increase in enzymatic 
activity. 
Early attempts to develop bypass grafts engineered from synthetic materials 
focused on the use of non-degradable polymers, such as Dacron™ or expanded polytetra 
fluoroethylene (ePTFE). When replacing larger vessels of 6-100 mm in diameter, these 
grafts were very successful, but when used in the coronary system where diameters are 3-
4 mm, thrombotic events rapidly closed them off. The next step, perhaps the beginning of 
tissue engineering as applied to the cardiovascular system, was the development of 
endothelial cell (EC)-seeded synthetic grafts, which was started in the mid 1970s. The 
major limitation of the earlier grafts was the thrombogenic blood-contacting surface. The 
thrombogenic surface is removed by coating EC onto the synthetic surfaces (Weinberg 
and Bell, 1986). To optimize EC-binding, various approaches were taken (Nerem, 2001). 
Impregnating bioactive molecules such as FGF-1, heparin and fibronectin into high-
density porous polyethylene and ePTFE was shown to enhance endothelial binding 
(Massia et al, 1991 and 1992; Chu et al, 1999; Can et al, 2000). These methods allow for 
continual mechanical support and favorable surfaces. Alternatively, combining 
techniques such as using contracted collagen as a medial layer with a polymeric outer 
tube, may provide both mechanical support and favorable surfaces (Matsuda et al, 1989). 
Another alternative is to use a less reactive surface. Implantation of Silastic tubing into 
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the peritoneal cavity of rabbits accelerated tissue formation and showed increased graft 
patency along with contractile properties in response to stimuli and the apparent creation 
of elastic lamina (Campbell et al, 1999). These studies have shown possible ways to 
reduce the immunogenic and thrombogenic problems but do not solve the chronic 
problem caused by material erosion. The use of a non-biodegradable synthetic material 
would hinder the normal remodeling response of the vascular system. Vascular cells are 
not equipped to remodel ePTFE or Dacron™ in the same way they remodel collagen and 
elastin. Thus, the synthetic material becomes a physical barrier to long-term adaptation of 
the vessel. Similarly, the vasoactive component of the vessel would be completely lost 
with a synthetic graft, hence the move to application of biodegradable polymers to 
generate autologous tissue. 
 
1.3 Biodegradable Polymers in Vascular Constructs 
A wide variety of both hydrophobic and hydrophilic polymers have been 
developed (Griffith, 2000; Saltzman, 1996). Degradable polymers undergo extensive 
chain scission to form small soluble oligomers or monomers in the presence of body 
fluids or in vitro culture. This degradation may proceed by a biologically active process 
(e.g. enzymes present in body fluids) or by passive hydrolytic cleavage. Degradable 
polyesters based on lactide and glycolide monomers have been the workhorse synthetic 
polymers for scaffold construction (Griffith, 2002). Synthetic polyesters like poly- 
lactide, poly-glycolide and poly ε-caprolactone have been shown to degrade mainly by 
simple hydrolysis of the ester bonds into acidic monomers, which can be removed from 
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the body by normal metabolic pathways. Other factors that affect degradation include 
hydrophobicity and molecular weight. 
Previous efforts to solve the problem in engineered vascular grafts have led to the 
application of biodegradable polymers for in vitro generation of an autologous tissue 
construct. Autologous cell seeding within biodegradable poly-glycolic acid scaffolds 
allows for structural support while cell proliferation and matrix deposition compensates 
for the biodegradation of the scaffold (Niklason et al, 1999; Shum-Tim et al, 1999). 
SMCs within the scaffold were cultured for several weeks under pulsatile radial stresses 
(Niklason et al, 1999). During this development process, cells produced large amounts of 
matrix proteins concurrently with the degradation of the polymer scaffolding. The 
constructs were maintained in a culture medium that was supplemented with 
biochemicals known to promote synthesis of structural ECM proteins. Following eight 
weeks of in vitro maturation, the constructs were comprised mostly of vascular cells and 
ECM. After the maturation process, porcine ECs were seeded onto the lumen of the 
construct to form a confluent monolayer. The initial findings demonstrated that these 
constructs exhibited burst pressures greater than 2000 mmHg and desirable histological 
characteristics. The difficulty in using a cell-seeded polymeric scaffold approach for 
engineering vascular constructs is the determination of culture conditions. In this respect, 
the mechanical and biochemical signals experienced by the developing tissue should 
promote optimal construct development as the polymer degrades. In the case of 
cardiovascular tissue, the use of a dynamic culture is clearly warranted.  
Although the biodegradable synthetic polymer-based approach brings much 
promise in terms of construct development, there are several issues that must still be 
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addressed. Firstly, eight weeks of in vitro development are required for the construct to 
exhibit the desired characteristics. To increase efficiency, remodeling competence could 
be improved by shortening the natural tissue developing time. There is also some concern 
about the presence of residual polymer within the vessel wall causing an inflammatory 
response. The mechanical properties of the degradable polyesters are not always suitable 
for the construct due to their relative inflexibility and tendency to crumble upon 
degradation or to break in the mechanically dynamic culture conditions. Degradation also 
has to be controlled to synchronize remodeling in careful consideration of loss of 
mechanical strength. 
 
1.4 MMPs in Vascular Remodeling 
Vascular remodeling to create any enduring change in the size and/or composition 
of an adult blood vessel, not only allows blood vessels to adapt and heal normally but also 
underlines the pathogenesis of major cardiovascular diseases, including atherosclerosis 
and restenosis. Physiological and pathological vascular remodeling entails degradation 
and reorganization of the ECM scaffold of the vessel wall, explaining the recent interest 
in the potential participation of specialized enzymes, called matrix metalloproteinases 
(MMPs). (Galis 2002). 
The current understanding of the role of MMPs in vascular remodeling has come 
from two sources: in vitro experimentation using vascular cells and in vivo models where 
MMPs have been identified within the vessel wall. In vitro experimentation has allowed 
control of MMP expression and activity, and investigation of subsequent effects upon 
cellular processes, such as cell migration and proliferation. In vivo models, on the other 
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hand, have allowed for investigation of global effects of MMPs in physiologic and 
pathologic vascular remodeling.  
Endothelial cells, the blood contacting cells lining the innermost layer of the 
arterial wall, have been shown to synthesize many MMPs as well as MMP inhibitors 
when cultured in vitro (Galis, 2002).  Studies of cultured endothelial cells have all shown 
a basal expression of MMP-2, also known as gelatinase A. However, the expression of 
other MMPs was shown to depend on the source of the cells, the culture conditions, and 
treatments employed (Jackson et al, 1997). 
SMCs, the major cell type in the artery wall, are important for the maintenance of 
vascular tone and mechanical properties. Cultured human SMCs have been found to 
constitutively express MMP-2 and have the capacity to express MMP-9 (also known as 
gelatinase B) under stimulation by cytokines (Galis et al, 1994). Migration of rat SMC 
through reconstituted basement membrane has been shown to be dependent on 
gelatinolytic activity (Pauly et al, 1994).  Increasing endothelial production of nitric oxide 
decreased production of MMP-2 and MMP-9 by SMC and reduced SMC migratory 
ability (Gurjar et al, 1999), indicating a role for MMP in enabling regulation of SMC by 
endothelial cells.  Another study has shown that over expression of tissue inhibitor of 
MMPs (TIMPs) in SMC affects SMC invasion, proliferation, and apoptosis (Baker et al, 
1998). Furthermore, MMP production in SMC is affected through an αvβ3 integrin 
(Bendeck et al, 2000 and Kanda et al, 2000). MMP-9 appears to be involved not only in 
degradation, but also in the reorganization of a collagenous matrix, both facets being 
essential for the outcome of arterial remodeling (Galis and Johnson, 2002). The potential 
role of MMPs has been shown as effectors of SMC dependent remodeling in a murine 
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model (Johnson and Galis, 2003). Knock-out of the MMP-2 and MMP-9 genes decreased 
SMC invasion in vitro and decreased formation of intimal hyperplasia in vivo by 81% and 
65%, respectively. However, it was found that MMP-9, but not MMP-2, was necessary 
for the organization of collagen by SMCs. Likewise, MMP-9 deficiency resulted in a 
50% reduction of SMC attachment to gelatin, indicating that SMCs may use MMP-9 as a 
communicator between the cell surface and the matrix. Understanding the specific roles 
of these MMPs, generally thought to be similar, could improve the design of therapeutic 
interventions aimed at controlling vascular remodeling. 
Ex vivo and in vivo models of vascular remodeling have also supported the 
potential role of MMPs. Organ cultures of human saphenous veins have shown that MMP 
expression and activity are modulated by flow conditions (Mavromatis et al, 2000) and 
that the expression of TIMPs is increased during neointimal formation (Kranzhofer et al, 
1999). In a mouse model of restenosis, we have shown that the time course of MMP-2 
and MMP-9 expression is different, suggesting that these two MMPs may differentially 
affect lesion progression (Godin et al, 2000). Studies have also shown that MMP 
inhibitors can induce regression of vascular lesions (Cowan et al, 2000) and MMP-9 
deficiency suppresses the development of abdominal aortic aneurysms in a mouse model 
(Pyo et al, 2000), suggesting inhibition as a possible treatment for these conditions. 
However, another study in mice has shown that while the inhibition of MMPs prevents 
cardiac rupture, it also impairs angiogenesis and ultimately leads to cardiac failure 
(Heymans et al, 1999). While the inhibition of MMPs might halt some of the pathological 
effects, it may also negatively impact necessary positive aspects of remodeling. 
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The experimental drivers of this study are development and fabrication of 
biodegradable polymer scaffolds and the investigation of the role of MMP-9 for 
improving remodeling of vascular tissue in these scaffolds. We hypothesized that MMP-9 
is necessary for cell-matrix interaction and remodeling process for the function and 
survival of the scaffolds. Vascular aortic smooth muscle cell (VASMC) interaction with 
the scaffolds can be improved by optimizing the biodegradable polymer. Specifically, we 
investigated the following major topics. 
 
2.1 Aim 1  
Investigation of the rate-dependent degradation effect of biodegradable polymers 
on in vitro three-dimensional (3D) cell cultures on scaffolds and in vivo host response to 
implants. Little had been studied about the degradation rate-dependent acidic byproduct 
effect of the scaffold, even though the degradation products of biodegradable polymers 
were shown to be non-cytotoxic. We developed thin biodegradable polymer scaffolds that 
have a highly porous structure to simulate a small diameter vessel or multi-layered media 
structure of aortas or big diameter arteries. We specifically investigated the degradation 
rate-dependent effects of in vitro 3D growth of VASMC on the biodegradable scaffolds 
and in vivo cell invasion mediated angiogenesis necessary for the function and survival of 
the implants. 
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Thin biodegradable polymer scaffolds could be employed for tissue engineered 
vascular constructs. On the other hand, previous studies implied that the rate of 
degradation might affect cellular function including cell proliferation, connective tissue 
synthesis and host response, even though the degradation products were shown to not 
have cytotoxic effects (Babensee,1998; Lewandrowski,2000). However, little had been 
clearly proved about how the acidic local environment, which was degradation rate-
dependent, affects the 3D cell culturing on the scaffold and the key consideration for in 
vivo scaffold implantation, namely, the in vivo host response such as inflammation and 
angiogenesis. For these purposes, we developed ten micron thick porous structured 
matrix scaffolds using various polymers: a fast degrading polymer (poly D,L-lactic-
glycolic acid co-polymer, PLGA, 50:50) and a slow degrading polymer (poly ε-
caprolactone, PCL). We investigated the impact of the polymer degradation rate on the 
viability of primary mouse aortic smooth muscle cells (MASMC) in vitro (on the 
scaffold) and in vivo (angiogenesis following cell invasion by implanting scaffolds in the 
backs of mice). This study would enable optimization of the degradation rate and the 
culture conditions for synchronization with the regeneration of vascular tissue.   
• Live/dead assay with Flow Cytometry analysis and multi-photon microscopy 
imaging were used for two-dimensional depth-independent and 3D depth-dependent 
viability of MASMC respectively. 
• Gel permeation chromatography (GPC) was used to measure the molecular 
weight change associated with in vitro and in vivo polymer degradation through 
interaction with cultured in vitro MASMC or implanting the scaffolds in the backs of 
mice. 
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• pH-sensitive fluorescent probes were used to determine the pH of the culture 
medium which was used for degradation of the polymer.  
• Inflammatory cell-specific Geimsa and EC-specific CD31 (PECAM-1) staining 
were used to investigate in vivo cell invasion and subsequent angiogenesis into the 
scaffolds.  
 
2.2 Aim 2 
The role of MMP-9 in cell-matrix interaction for remodeling and the 
functional survival of the constructs containing biodegradable polymer scaffolds. We 
investigated the in vitro degradation properties of MMP-9 on collagen and 
biodegradable polymer scaffolds. The potential role of MMP-9 for collagen 
remodeling was investigated specifically upon biochemical stimulation. We 
investigated the role of MMP-9 in the in vivo cellular invasion into implanted 
scaffolds and subsequent angiogenesis. 
It was previously reported that the initial improvement of mechanical properties 
in collagen and VSMC constructs would ultimately be lost. Dr. Galis hypothesized that 
the scaffold of collagen-based tissue constructs is degraded by specialized enzymes, 
called matrix metalloproteinases (MMPs). Recently Dr. Galis’ lab demonstrated that 
cultured SMCs produce MMPs, and production of MMPs by the SMC-seeded collagen 
vascular constructs in vitro and showed that MMP-9 was involved not only in 
degradation, but also in reorganization of a collagenous matrix, both facets being 
essential for the outcome of arterial remodeling (Johnson and Galis, 2004).  We proposed 
that biodegradable polymers can offer an alternative solution, so we can preserve the 
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beneficial effect of MMPs, especially MMP-9, upon the organization of the tissue 
engineered construct, and improve the collagen production, deposition, and organization, 
namely remodeling modulated by MMP-9 especially upon ascorbic acid treatment.  
Furthermore, we investigated the role of MMP-9 in vivo. Specifically, we implanted the 
biodegradable scaffold in the backs of MMP-9 transgenic Knock Out (MMP-9KO) and 
Wild Type (WT) mice and observed inflammatory cell invasion into the biodegradable 
polymer scaffold following angiogenesis using a newly developed fluorescence 
microangiography method. In order to assess the roles of MMP-9, we performed the 
following experiments: 
• Real time- RT PCR was used to measure collagen mRNA production.  
• 3H-Proline incorporation assay was used to measure collagen protein 
accumulation to investigate degradation properties of MMP-9.  
• Gel permeation chromatography (GPC) was used to investigate the effect of 
MMP-9 on the in vitro or in vivo degradation of biodegradable scaffolds.  
• A novel quantitative assay using FITC labeled collagen was applied to investigate 
the effect of ascorbic acid associated with MMP-9 on collagen assembly (Johnson and 
Galis, 2003).  
• Inflammatory cell-specific Geimsa staining was used for investigating the effect 
of MMP-9 in vivo on inflammatory cell invasion into the implanted scaffolds.  
• Newly developed fluorescence microangiography with multi-photon microscopic 
imaging and quantitative xylene tissue extraction method was applied to examine MMP-9 
influence on in vivo formation of angiogenesis and perfusion.  
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2.3 Aim 3 
Optimization of composition and fabrication conditions for blending two 
biodegradable polymers that enhance properties of affected MASMC using combinatorial 
biosurface chips.  We developed a poly lactic-co-glycolic acid (PLGA) and poly ε-
caprolactone (PCL) blended combinatorial surface chip based on concentration and 
annealing temperature gradients. Using these combinatorial chips, we hypothesized that 
the phase separation mediated polymer properties by determining specific concentration 
and annealing temperature that could determine improved MASMC interactions.   
A “combinatorial biosurface chip” technology has been developed for high-
throughput assays of the effects of polymer surface chemistry and structure on cell 
function. This technology allows rapid screening of thousands of surfaces in order to 
design novel biomaterials or scope out variables prior to detailed culturing experiments, 
because libraries containing hundreds to thousands of distinct chemistries, 
microstructures, and roughness are prepared using composition spread and temperature 
gradient techniques (Meredith, 2003). In terms of controlling degradation rate and getting 
possible synergistic effects of combination, we decided to blend PLGA and PCL, and 
thus developed new combinatorial chips comprised of PLGA and PCL. MASMC 
population assays on the chips indicated that specific surface structures and properties 
could be regulated to enhance MASMC interaction. Therefore, we investigated the area-
dependent variation of surface microstructure using various surface analysis techniques. 
Also, we tested cell adhesion, cell viability, and cell proliferation to verify which of the 
cell properties were affected by area-dependent property and caused the increase in cell 
populations in certain areas. Then, we measured area-dependent changes of various 
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surface properties such as roughness, composition, hardness, and crystallinity to 
investigate which surface properties strongly correlated with the enhancement of the 
verified cell properties. Finally, we tested the correlation between the determined optimal 
surface and cell properties with uniform individual samples that represented each specific 
surface property. We investigated protein-mediated cell interaction with the polymer 
surface, observing the change of area-dependent protein production. We conducted the 
following experiments with newly developed combinatorial chips with PCL and PLGA.  
• Cyber-green nucleus staining was examined using fluorescence microscopy and 
phospho-image scanning were applied to determine cell coverage of the chips. 
• BrdU incorporation and live/dead assay were used for cell proliferation and 
viability tests.  
• Reflected and polarized microscopy were used for macroscopic reconstruction of 
the entire chip surface. Atomic force microscopy (AFM) was applied to measure the 
roughness and hardness of the surface. 
• Differential scanning calorimeter (DSC) and X-ray Photon Microcopy (XPS) 
were used to measure the surface crystallinity and composition respectively. 
• Radioisotope-labeled protein incorporation assay was applied for non-specific 





                                           
                                                                                                                        
16
CHAPTER 3  
The Effect of Scaffold Degradation Rate on Three-Dimensional Cell Growth and 
Angiogenesis 
 
Sung H-J, Meredith JC, Johnson C and Galis ZS. Biomaterials. 2004; [in press] 
 
3.1 Abstract  
Even though degradation products of biodegradable polymers are known to be 
largely non-cytotoxic, little detailed information is available regarding the degradation 
rate-dependent acidic byproduct effect of the scaffold. In vitro and in vivo scaffold 
degradation rate could be differentiated using a fast degrading polymer (e.g., poly D, L-
lactic-glycolic acid co-polymer, PLGA, 50:50) and a slow degrading polymer (e.g., poly 
e-caprolactone, PCL). We applied a new method to develop uniform 10 µm thickness of 
high porous scaffolds using a computer-controlled knife coater with a motion stage and 
exploiting phase transition properties of a combination of salts and water in salt-leaching 
method. We then verified in vitro the effect of fast degradation by assessing the viability 
of primary mouse aortic smooth muscle cell (MASMC) cultured in the three-dimensional 
(3D) scaffolds. We found that cell viability was inversely related to degradation rate and 
was dependent on the depth from the seeding (upper) surface toward the lower surface. 
The pH measurement of culture medium using fluorescence probes showed time 
dependent decrease in pH in the PLGA scaffolds, corresponding to PLGA degradation, 
and closely related to cell viability. In vivo analysis of scaffolds implanted 
subcutaneously into the back of mice, showed significant differences in inflammation and 
cell invasion into PLGA vs. PCL. Importantly, these were correlated with the degree of 
the functional angiogenesis within the scaffolds. Again, PLGA scaffolds demonstrated 
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less cell mobilization and less angiogenesis, further supporting the negative effect of the 
acidic environment created by the degradation of biocompatible polymers.  
Key words: Biodegradable polymer; degradation; cell viability; pH; inflammation; 
angiogenesis.   
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3.2 Introduction 
Synthetic biodegradable polymers have been used extensively for scaffold 
fabrication in tissue engineering applications because they can enhance the properties of 
constructs specifically the mechanical properties, while allowing control of degradation. 
Good biocompatibility and possibility to processed into desired configurations add to 
their popularity. A desirable feature would be synchronization of polymer degradation 
with the replacement by natural tissue produced from cells. Therefore, the degradation 
properties of a scaffold are of crucial importance for biomaterial selection and design but 
also the long-term success of a tissue-engineered construct.  
We have used in our study poly D, L-lactic-glycolic acid co-polymer (PLGA) and 
poly e-caprolactone (PCL), previously studied in respect to porosity, behavior in static 
and flow conditions, with temperature and cyclic loading (Athanasiou et al, 1998; 
Agrawal et al, 2000 and 1998; Thomson et al, 1996). Both polymers have been shown to 
degrade mainly by simple hydrolysis of the ester bond into acidic monomers, which can 
be removed from the body by normal metabolic pathways. Other factors that affect 
degradation include hydrophobicity (Lu et al, 2000) and molecular weight (Lu et al, 
1999; Miller et al, 1977). The degradation of a block co-polymer such as PLGA is 
affected by the ratio of hydrophilic poly glycolic acid (PGA) to hydrophobic poly lactic 
acid (PLA). PCL that has higher molecular weight with higher hydrophobicity than 
PLGA will degrade more slowly. The biocompatibility of these polymers also has been 
demonstrated in biological applications (Zentner et al, 2001; Hasirci et al, 2001; Kweon 
et al, 2003; Rizzi et al, 2001) and the previous reports implied that the rate of degradation 
might affect cellular interaction including cell proliferation, tissue synthesis and host 
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response (Babensee et al, 1998; Lewandrowski et al, 2000). However, details of the 
potential effects of the acidic byproducts on the 3D cell culture or upon in vivo host 
response remain understudied. 
We are interested in developing small diameter tissue engineered vascular 
constructs and thus for the purpose of this study we developed 10 micron thick porous 
biodegradable scaffolds. We investigated polymer degradation and rate-dependent effects 
comparing a fast degrading polymer (PLGA, 50:50 ratio of PGA to PLA) and a slow 
degrading polymer (PCL). MASMCs were cultured in vitro on the scaffolds and we 
assessed cell viability and measured the degradation rate dependent pH change of culture 
medium. We also implanted the scaffolds in vivo and investigated in time their population 
by cells, especially by inflammatory cells. Interestingly, we found that the degree of 
inflammation was related to the level of vascularization of implants through 
angiogenesis. 
 
3.3 Materials and Methods 
Scaffold fabrication. We used salt leaching to develop a porous structure as 
follows. Poly DL-lactide-co-glycolide (PLGA; Sigma Aldrich, St Louis, MO) with a 
50:50 ratio of PGA and PLA and a molecular weight range of 40,000-75,000 Da and poly 
ε-caprolactone (PCL; Sigma; Mw =114,000 Da) were dissolved by solvent casting from 
chloroform (Sigma). Salt crystals were generated by exploiting phase transition 
properties of a combination of salts and water. The salt size was controlled by ultra-
sonication time and filter size in the final step and calculated by image analysis of 
Scanning Electron Microscope (SEM) at random 20 pores of each three samples of the 
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both polymers. Computer-controlled knife coater with a motion stage (Meredith et al, 
1997) was used to generate an average 10µm thick polymer matrix, at a constant velocity 
and angle. 
MASMC culture and polymer seeding. SMCs were harvested from explanted 
aortas of wild-type mice as previously described (Galis et al, 2002). Cells were grown in 
DMEM (Cellgro, Herndon, VA) supplemented with 10% FBS (Sigma). SMC were 
seeded (1x105) onto polymer discs cut to fit into 24-well plates. Culture medium was 
changed twice weekly throughout the experiments. Discs were analyzed at 1, 7, 14, 21 
and 28 days post-seeding. 
Subdermal scaffold implantation in mice. The polymer discs were sandwiched 
between two nitrocellulose filters (Millipore, Boulder, CO) to block the non-specific 
tissue in-growth into the polymer. The discs were subcutaneously implanted in the back 
of wild type 129/SvEv mice. The discs were harvested at 7, 14, 21 and 28 days post 
implanting for analysis. 
Polymer degradation assay. The polymer molecular weight distribution for the 
sample polymer discs was determined by gel permeation chromatography (GPC) (Perkin-
Elmer, Wellesley, MA) equipped with a refractive index detector (Perkin-Elmer). The 
dried samples were dissolved in tetrahydrofuran at a concentration of 8 mg/ml and eluted 
through the column at a flow rate of 1 ml/min at 37 °C. Polystyrene standards 
(Polysciences, Warrington, PA) were used to obtain a primary calibration curve. All 
samples of the same polymer type were analyzed at a single run. Variability in the 
determination of the both polymer molecular weight by GPC for undegraded samples was 
about 1% relative standard deviation. 
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SMC viability test. For two dimensional viability tests, MASMCs were 
dissociated from the scaffolds using an enzyme solution consisting of 100U collagenase 
1A (Sigma) and 250 µg trypsin (Sigma) and incubated at 37 °C for 1 hour (Grafe et al, 
1994). Cell viability was determined by staining with 3 µM calcein (Molecular Probes 
Inc., Eugene, OR) and non-viable cells were visualized by staining with 20 µM 
propidium iodide (PI) (Sigma) followed by flow cytometric analysis (Becton Dickinson, 
San Jose, CA) (Park et al, 2000).  
3D sectional cell viability through the thickness of the polymer (from the upper to 
lower surface) was measured using optical sectioning of 3 µm intervals with a multi-
photon LSM510 microscope (Zeiss, Oberkochen, Germany) fitted with a NLO 800 nm 
laser. Staining of SMC with calcein, PI and Hoechst 33342 (Sigma) for nuclei 
counterstaining was performed without dissociation from the scaffold. At each optical 
section, the total cell number was counted as total blue stained (Hoechst) nuclei. The 
viable and dead cell number was counted as green (calcein) and red (PI) cells 
respectively. We defined cells that stained with both calcein and PI as dying cells. The 
viability was calculated as a percentage of green stained cells out of the total cell number. 
Average cell viability was calculated for three regions: top surface, inner layer, and 
bottom layer. 
Scanning electron microscopy (SEM). The scaffolds were air-and vacuum-dried, 
and their surfaces were prepared for observation with the SEM at the beginning and end 
of the observation period. The polymer samples were gold coated using a sputter coater 
(Pelco sputter coater 91000) set at 20 mA for a total time of 120 s (coating thickness, 
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approximately 40 nm). The specimens then were imaged with JSM-5300 SEM (JEOL, 
Peabody, MA) operated at 20 kV. 
Measurement of pH with fluorescence probe. To determine the effect of 
degradation on the pH around the scaffolds, the polymer discs were incubated in phenol-
red free DMEM at 37°C for 1, 7, 14, 21 and 28 days. To determine pH, 10µl of 10 µM 
fluorescein (Sigma) was incubated with 1ml culture medium for 10 min at 37°C 
(Haugland et al, 1999). Fluorescence was measured using a CytoFluor multi well plate 
reader (Perseptive Biosystems, Framingham, MA) set at 485 nm excitation and 530 nm 
emission. A standard curve was generated by adding either HCl or NaOH to the phenol-
red free DMEM to give pH values in the range of 5-8, followed by the addition of the 
fluorescein and measurement in the CytoFluor.  
In vivo host reaction to implanted scaffolds. Implanted PLGA or PCL discs were 
harvested at 7, 14 and 28 post-implantation. The harvested disc was frozen-embedded 
with O.C.T compound (Tissue-Tek®, Sakura Finetek, Torrance, CA) in liquid nitrogen 
and sectioned using a cryostat (Leica, Nussloch, Germany). All cell nuclei were 
counterstained using hematoxillin-eosin. For detection of inflammatory cells we 
performed Geimsa staining (Richard-Allan Scientific, Kalamazoo, MI) at 45 °C for 30 
min and differentiated in 1% acetic acid solution. In Geimsa staining, the negatively 
charged phosphoric acid groups of DNA attract the purple polychromatic dyes. The blue 
basophilic granules are stained by the polychromatic cationic dyes. Cationic cellular 
components such as erythrocytes and eosinophilic granules are stained by red and pink 
anionic dyes.  
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In vivo angiogenesis. Immunohistochemical staining to identify vasculature was 
performed using the endothelial specific marker CD31 (PECAM-1) on sections of the 
frozen-embedded disc using rat anti-mouse PECAM-1 (Santa Cruz Biotechnology Inc., 
Santa Cruz, CA) followed by Rhodamine Red X (RRX)-labeled goat anti-rat IgG 
(Jackson ImmunoResearch Laboratories Inc, West Grove, PA). Nuclei counter staining 
was performed with Hoechst 33258 (Sigma) to identify the areas of cell invasion. As a 
measure of angiogenesis, red colored PECAM-1 positive areas were measured and 
normalized by the total cellular area determined by blue nuclear staining. 
Statistical analysis. All data is shown as mean ± standard error. The paired 




Scaffold fabrication.  After preparing the polymer a disc, scanning electron 
microscopy (SEM) was used to verify the uniformity of the thickness and the pore size of 
each disc [Figure 1]. Changing the weight ratio of the salts to polymer controlled the 
scaffold porosity. The ratio of the salts to polymer was 4.4 to 1, thus the porosity was 
calculated to approximately 80% (Agrawal et al 2000). The maximum porosity was 
found to be 90%, as the 10 µm thickness thin polymer lost its mechanical strength at such 
high porosity (data not shown). The pore sized distributed to 8.2± 1.8 µm in PLGA and 
9.8± 0.6 µm in PCL. They showed somewhat different size distribution because of 
viscosity, but overall pore size could be controlled less than 10 microns diameter.  
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Two- and three-dimensional cell viability test on the polymers.  The two-
dimensional (2D) viability of MASMC cultured on either type of polymers were 
compared against that of MASMC cultured in tissue culture plates (TCPS), for up to 28 
days in culture. We found patterns of decreasing SMC viability on both polymers [Figure 
2]. The 2D viability on PLGA was significantly lower than that on TCPS at 7, 21 and 28 
days post-seeding. In comparison with PLGA, the viability on PCL was not significantly 
decreased compared to that on TCPS for the time investigated. 
The 3D viability test showed that MASMCs cultured on the surface of the scaffolds 
migrated into the scaffold through the inter-connected porous structure [Figure 3(a)]. Overall, 
at later time points cell viability decreased from the upper towards the lower surface of the 
scaffold. A significant decrease in cell viability within the scaffold compared to the upper 
surface of PLGA was detected starting at 14 post-seeding [Figure 3(b)]. In comparison, the 
significant decrease in cell viability was detected only at 28 days for PCL.  
In vitro polymer degradation.  GPC data confirmed that the two polymers 
degraded at different rates [Figure 4(a)]. Initially, the measured molecular weight was 
40,000±200 Da for PLGA, while it was 114,000 ± 350 Da for PCL. The molecular 
weight of PLGA had significantly decreased by 14 days (18%) and decreased to 56% 
±1% (p<0.01) by 28 days. PCL degradation was slower, showing only a statistically 
significantly decrease at 21 days (33%) and 28 days (39% ±1%, p<0.001). 
SEM micrographs illustrated the time-dependent morphological change of both 
polymer scaffolds [Figure 4(b)]. Significant morphological changes of PLGA could be 
seen at 14 days, with the disruption of internal structure changing the surface 
morphology. PCL showed relatively little change in morphology at 14 days. Huge 
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disruption of inter-connected structure and changes in surface morphology was seen in 
PLGA at 28 days, while PCL scaffold structure appeared less affected. 
Effects on pH.  As polymer degradation leads to acidic byproducts, we 
investigated the potential effects on the pH surrounding the scaffolds. The pH 
measurements were performed in the absence of cells to eliminate potential changes 
caused by cell growth [Figure 4(c)]. In comparison with TCPS, the pH of medium with 
the PLGA discs was lower from 1 day through 28 days. PLGA degradation caused a 
significant decrease in pH by 7 days and continued decreasing to a final 0.5 pH units by 
28 days. However, there was no significant decrease and difference of pH change 
between TCPS and PCL over the entire period investigated (28 days).  
In vivo polymer degradation.  In vivo degradation of PLGA or PCL discs 
implanted subdermally on mice was measured by GPC. The measured in vivo rates of 
degradation were found to be faster than those measured in vitro [Figure 4(d)]. The 
molecular weight of PLGA had decreased by 7 days and continued to decrease by 73.5% 
± 6.5% (p<0.05) at 28 days. This degradation was significantly faster than in vitro 
degradation (56 ± 1% at 28 days, p<0.001). PCL degraded more slowly than PLGA in 
vivo, degradation reaching significance by 21 days at 46.2% ± 2.3% (p<0.05). The 
degradation of PCL  in vivo was also faster than that in vitro after the same length of time 
(39 ± 1% at 28 days, p<0.001), supporting the notion that the degradation rate of 
polymers depends on the environment. 
In vivo inflammatory cell invasion.  We found that the cell density in the polymer 
regions remaining at 28 days was greater in the PCL compared to PLGA scaffolds [Figure 
5(a)]. Taking into consideration the different degradation rates, the cell data was 
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normalized to polymer area [n=3 for each time point] to obtain a measure of cell migration 
into the scaffold. We found that a significantly greater number of total cells migrated into 
PCL than PLGA at all time points, the increased acidic environment likely inhibiting cell 
migration. We also determined that migration of inflammatory cells followed a similar 
trend at 7 and 14 days. At longer time points, we did not find a statistical difference in the 
migration of inflammatory cell into the polymers, however at this time point quantification 
was less reliable due to significant polymer degradation. 
 In vivo angiogenesis.  To measure the extent of angiogenesis within the implanted 
scaffolds, we detected the endothelial cell specific marker CD31 in histological sections 
of scaffold harvested at various times after implantation [Figure 5(b)]. We hypothesized 
that more in vivo cell invasion relating with inflammation [Figure 5(a)] would result in a 
greater angiogenic response. A higher density of CD31 positive cells was detected in the 
PCL than PLGA from 14 to 28 days. The CD31 positive area was normalized to total 
tissue area [n=3 for each time point] to determine the extent of angiogenesis. 
Significantly more angiogenesis was observed in PCL than PLGA scaffolds from 14 to 28 
days, supporting the hypothesis that angiogenesis was related to increased invasion of 
scaffolds, specifically by inflammatory cells.  
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3.5 Figures and Legends 
  
 
Figure 1.  PLGA can be used to create thin porous scaffolds of uniform thickness. 
Morphology of a PLGA scaffold as visualized by scanning electron microscopy (SEM). 
Left and right pictures demonstrate the possibility to control the scaffold thickness (left: 
15 µm, right: 10 µm). Center image illustrate a surface view. Pore size: < 10 µm. 




                                           
































Figure 2.  Detection of cell viability using primary cultured mouse aortic smooth muscle 
cells (MASMC). Two-dimensional viability was measured for cells cultured on PCL or 
PLGA scaffolds compared to that of cells maintained under regular cell culture 
conditions, on a tissue cell culture plastic surface (TCPS) for up to 28 days. The means 
obtained from 4 independent experiments ± SEM are shown. The viability was decreased 
at short time points on PLGA, then at later time points also on PCL. (*) P < 0.05 for 
PLGA vs. TCPS and (†) P < 0.05 for PCL vs. TCPS.   
 
                                           



































































Figure 3.  Cell viability within scaffolds (three dimensional, 3D) decreased with depth 
and as a function of time. Polymer discs cultured with MASMC for various length of 
time were analyzed by multi-photon microscopy using z-series at 3 micron interval 
optical sections. Top panels (a) illustrate cell viability in the three main regions (upper 
surface, middle region, bottom surface) after culture on PLGA (left) and PCL (right) for 
1, 14, 28 days (viable cells are green, dead cells are red, all nuclei are blue) (b) 
Quantitative analysis of 3D viability in the three regions of PLGA (left) and PCL (right) 
scaffolds. The mean values obtained from 3 experiments ± SEM are shown. (*) P < 0.05 
for surface vs. the other layers - internal and bottom layers. 
 
                                           












































































































Figure 4.  Characterization of PLGA and PCL scaffolds degradation in vitro and in vivo. 
(a) Measurement of in vitro degradation by GPC. Y-axis represents the % of starting 
molecular weight (Mw). Error bars represent SEM for n=3. (*) P < 0.05 for percent 
decrease from previous value for PLGA degradation and (†) P < 0.05 for percent 
decrease from previous value for PCL degradation. (b) Investigation of scaffold 
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morphology by SEM reveals effect of degradation at 14 and 28 days compared to day 0. 
(c) The environment pH changed as function of polymer and time, as measured using 
fluorescent probes. (∆) Media minus scaffold (negative control), (ڤ) PCL and (x) PLGA. 
The mean values obtained from 4 experiments ± SEM are shown. (*) P < 0.05 for each 
polymer vs. control (culture medium alone) and (†) P < 0.05 for the value change 
compared to the previous value. (d) Degradation of polymer scaffolds was faster in vivo, 
measurement by GPC – compare to graph illustrated in (a). Y-axis represents the % of 
starting molecular weight (Mw). The mean values obtained from 3 experiments ± SEM 
are shown. (*) P < 0.05 represents PLGA value compared to value at previous time point 
and (†) P < 0.05 represents PCL value compared to previous time point for PCL. 
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Figure 5.  Analysis of cell population of biodegradable scaffolds PLGA (right panel) and 
PCL (left panel) implanted in vivo was determined initially (day 0) and at 14 and 28 days 
(frozen sections). (a) Presence of cells is indicated by the purple nuclear staining. 
Inflammatory cells are detected by Geimsa staining (blue and pink staining). 
Quantification of total cell density (right upper graph) and inflammatory cell density 
(right lower graph) indicated a significantly increased cell invasion into PCL vs. PLGA 
scaffolds implanted in vivo. (b) To determine the extent of angiogenesis, frozen sections 
were stained with an antibody against the endothelial marker CD31 (PECAM-1). Positive 
profiles were detected using red fluorescence. All nuclei were counterstained with 
Hoechst (blue). The data obtained for endothelial positive staining, considered to 
represent angiogenesis, normalized to polymer area for both PLGA and PCL, indicated a 
significantly increased vascularization of PCL scaffolds implanted in vivo. Error bars 
represent SEM for three separate implanted scaffolds (n=3). (*) P < 0.05 for PLGA vs. 
PCL. 
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3.6 Discussion  
This study demonstrated the negative effect of fast degradation of scaffolds upon 
the in vitro viability of cultured primary SMCs. Analysis of scaffolds implanted into the 
back of mice, further supported this observation by showing less population with cells 
and angiogenesis within rapidly degrading scaffolds. We suggest that these effects were 
due at least partially to the increasingly acidic environment resulting from the 
degradation of PLGA vs. PCL. Use of dynamic flow would likely reduce the buildup of 
the acidic local pH of PLGA.  
We also report a method to control the thickness of biodegradable scaffolds using 
a knife-edge coater with a computer-controlled motion stage at a constant velocity and 
angle. Pore size within the scaffold was controlled by the use of phase-transitional salts. 
For our particular application we created 10 µm scaffolds with pore of 8.2± 1.8 µm for 
PLGA and 9.8± 0.6 µm for PCL. Such scaffold will likely be useful to generate a highly 
porous 3D structure to optimize growth of vascular SMCs from aortic media (Ishii et al, 
2001; Li et al, 2003).  
We found that degradation of scaffolds made of either PLGA or PCL was faster in 
vivo than in vitro. Hydrolysis of PLA-PGA and PCL materials is influenced by the 
concentration of carboxylic acid end-groups, thus the degradation products of those 
materials may serve as catalysts for the reaction in static conditions, which likely 
accelerate degradation (Li et al, 1990; Therin et al, 1992). We also confirmed that more 
hydrophilic side chains and lower molecular weight of PLGA accelerated its degradation 
compared to PCL (Giunchedi et al, 2003). On the other hand, our study suggest that it is 
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possible to accelerate the degradation of PCL, which although popular as a soft and hard-
tissue compatible material had somewhat limited application because of its slow 
degradation kinetics. Various approaches have been previously employed to enhance its 
degradability, for example, PCL diol with acryloyl chloride (Kweon et al, 2003). 
However, degradation is also affected by the scaffold thickness and porosity. In our 
application, the faster than expected of PCL degradation was likely related to the fact that 
the PCL thin films had a greater surface area to volume ratio and thus a greater water 
uptake (Lu et al, 1999).  
We found that the population with cells of scaffolds implanted in vivo was also 
dependent on the nature of the scaffold. Under similar conditions, the population of 
scaffolds with host’s cells, specifically with inflammatory and endothelial cells, were 
found to be significantly lower in the PLGA compared to the PCL scaffolds, suggesting 
that the acidic pH and/or the rapid degradation of the scaffold prevented integration. 
Thus, we suggest that PCL may be more desirable for the survival of thin scaffolds 
implanted in vivo. Interestingly, the degree of inflammation seemed to be related to the 
degree of angiogenesis, further demonstrating the biocompatibility of degradation 
products (Perugini et a, 2003). Importantly, our results support the necessity of eliciting 
an appropriate host inflammatory responses in order to enhance the local recruitment of 
vasculature to tissue engineered constructs, essential for their integration as well as the 
long-tern survival and function.   
Conclusion: We developed 3D biodegradable scaffolds using a new method to 
control the thickness using a knife-edge coater with a computer-controlled motion stage 
and the pore size using phase-transitional salts. The comparative study of fast vs. slow 
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degrading 3D scaffolds indicated that fast degradation negatively affects cell viability and 
migration into the scaffold in vitro and in vivo. This effect is likely due to the significant 
acidification of the local environment due to the polymer degradation. We also report that 
the angiogenic response developed within the scaffolds implanted in vivo was related to 
the presence of inflammatory response. Our results should contribute to a better 
understanding of the cell-biodegradable scaffold interactions necessary to optimize the 
manufacturing and survival of tissue constructs. 
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CHAPTER 4 
Matrix  Metalloproteinase (MMP)-9 Facilitates Cell-Matrix Interactions for 
Function and Survival of Vascular Constructs 
 
Sung H-J, Johnson CE, Magid R, Lessner SM, Drury DN and Galis ZS. Tissue Eng; [in 
review]  
 
4.1 Abstract  
Degradation of the extracellular matrix, facilitated by matrix metalloproteinases 
(MMPs), can lead to mechanical failure of vascular constructs, suggesting that MMP 
inhibition could improve survival of constructs. Therefore, we investigated the role of 
MMP-9 for in vitro collagen remodeling by smooth muscle cells (SMC), focusing on 
three major steps of production, degradation and organization. Since an adequate blood 
supply is essential for survival of tissue-engineered constructs, we also evaluated the 
influence of MMP-9 deficiency on vascularization of in vivo implant thin biodegradable 
polymer scaffolds. Using aortic smooth muscle cells (SMC) from wild type (WT) and 
MMP-9 genetically deficient (9KO) mice, we examined the role in MMP-9 on collagen 
mRNA expression and protein accumulation, both with and without ascorbic acid 
treatment. We measured effect upon collagen assembly using a fibrillogenesis assay. We 
investigated in vivo angiogenesis and cell invasion using fluorescence microangiography 
and histology. MMP-9 deficiency did not affect collagen mRNA production or polymer 
scaffold degradation, but collagen accumulation was greater in cultures of 9KO than in 
WT SMC. Both genetic deficiency and chemical inhibition of MMP-9 impaired collagen 
degradation. Ascorbic acid treatment enhanced collagen production by 9KO compared to 
WT SMC at 3 days, but by 7 days this effect was reversed, likely due to impairment of 
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collagen fibril formation. MMP-9 deficiency dramatically decreased inflammatory cell 
invasion as well as capillary formation within biodegradable polymer scaffolds in vivo. 
Our data suggest that MMP-9 inhibition, by impairing collagen organization and 
angiogenesis, might have detrimental effects on the survival of vascular constructs.   
Key words: matrix metalloproteinase-9; remodeling; collagen matrix; biodegradable 
polymer; inflammation; angiogenesis.   
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4.2 Introduction 
We previously defined vascular remodeling as any enduring change in the size 
and/or composition of an adult blood vessel, allowing adaptation and repair (Galis et al, 
2002). On the other hand, inappropriate remodeling, including its absence, underlies the 
pathogenesis of major cardiovascular diseases, such as atherosclerosis and restenosis. 
Physiological and pathological vascular remodeling entails degradation, production and 
reorganization of the extracellular matrix (ECM) of the vessel wall, explaining the recent 
interest in the potential participation of specialized enzymes, called matrix 
metalloproteinases (MMPs) (Galis et al, 2002). Mechanical stimulation of cell-seeded 
collagen gels induced further remodeling, resulting in enhanced mechanical properties 
(Seliktar et al, 2000 and 2003). However, the initial improvement of mechanical 
properties was ultimately lost, likely due tot the matrix degrading activity of MMPs 
secreted by the cells seeded in the constructs. This action seems analogous to mechanism 
leading to the mechanical failure of native arteries, where vascular pathologies have been 
associated with inappropriate degradation of the extracellular matrix scaffold of the 
arteries by MMPs (Galis, 1999).  
MMP-9 (also known as gelatinase B) is necessary for the regulation of SMC 
replication and migration after arterial injury (Cho and Reidy, 2002; Johnson and Galis, 
2004) and increased in perivascular inflammatory cell responses (Gurer et al, 2003; 
Ferroni P et al, 2003). Interestingly MMP-9 also appears to be involved not only in 
degradation, but also in reorganization of ECM (Galis et al, 2002), both facets being 
essential for the outcome of arterial remodeling (Mason et al, 1999). We also found that 
MMP-9 and MMP-2 considered to have similar functions actually differ in their actions 
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related to SMCs interactions (Johnson and Galis, 2004). Monocytes cultured on collagen 
type I also released more MMP-9 than did cells plated directly on plastic (Wesley et al, 
1998).  
Angiogenesis is an essential component of a variety of physiological and 
pathological processes, and thus offers attractive opportunities to improve survival of 
implanted scaffolds. Angiogenesis triggered by tissue ischemia requires MMP-9, which 
appeared to be necessary for capillary branching and to be supplied by macrophage 
(Johnson and Sung et al, 2004), consistent with MMP participation in an inflammatory 
response (Silvestre et al, 2001).  
Thus, we have decided to examine in more detail the value of using MMP-9 
inhibition in order to preserve the integrity and function of tissue-engineered constructs. 
We first examined the hypothesis that biodegradable polymers may offer a solution for 
preserving the mechanical strength of scaffold matrix without necessity to inhibit the 
potential beneficial effect of MMPs, especially of MMP-9. However, addition of a 
synthetic biodegradable scaffold to the tissue engineered constructs involves the 
understanding of the effects of such materials upon the remodeling and integration of 
constructs in general and, particularly potential interference with the actions of the cell-
secreted MMP-9. We investigated these issues using MMP-9 KO SMC and mice 
compared to the WT counterparts.  
 
4.3 Materials and Methods  
Scaffold fabrication. We used salt leaching to develop a porous structure as 
follows. Thin poly ε-caprolactone (PCL; Sigma; Mw =114,000 Da) films were solvent 
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cast from chloroform (Sigma). Salt crystal size was controlled under 10µm diameter by 
exploiting phase transition properties of a combination of salts and water. A computer-
controlled knife-edge coater with a motorized stage (Sung et al, 2004) was used to 
generate an average 10 µm thick polymer matrix, at a constant velocity and angle.  
Mouse Aortic SMC (MASMC) isolation and culture. SMCs were harvested from 
explanted mouse aortas as previously described (Galis et al, 2002). We isolated cells 
from MMP-9 Knock-Out (KO) mouse strains with its strain matched wild-type 
counterparts, to allow for direct comparison. Cells were grown in DMEM (Cellgro, 
Herndon, VA) supplemented with 10% FBS (Sigma). SMC were seeded (1x105) onto 
PCL polymer discs cut to fit into 24-well plates or directly into 24-well culture plates. 
Culture medium was changed every day with or without 50 µM ascorbic acid (Sigma) 
throughout the experiments. Experimental analyses were performed at 3, 7, and 14 days 
post-seeding.  
Subdermal scaffold implantation in mice. The PCL polymer discs were 
sandwiched between two nitrocellulose filters (Millipore, Boulder, CO) to constrain 
tissue growth into the polymer to two dimensions. The discs were subcutaneously 
implanted in the backs of MMP-9 KO and wild type 129/SvEv mice. The discs were 
harvested for analysis at 7 and 14 days post implantation. 
Collagen mRNA production. Mouse collagen type 1 messenger RNA was 
quantified using quantitative real time reverse transcription PCR (SYBR Green method) 
on a LightCycler (Roche Applied Science, Indianapolis, IN). Total RNA was isolated 
using the RNeasy Kit (Qiagen, Valencia, CA) according to the manufacturer's 
instructions, including on-column DNA digestion (RNase-free DNase kit, Qiagen) to 
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avoid genomic contamination. One microgram of RNA was reverse transcribed with 
Superscript II (Invitrogen, Carlsbad, CA). For quantification of collagen type 1, samples 
were run against a six-log standard curve of known plasmid concentrations (IMAGE 
clone 3466203) and normalized by 18 S rRNA level. Primers for normalization were 
QuantumRNA Classic II (Ambion, Austin, TX). The primers used for collagen type 1 
amplification were 5'-GTCTGGTTTGGAGAGAGCATGA-3' (upper strand at 5) and 5'-
CACAAGGGTGCTGTAGGTGAAG-3' (lower strand at 271). To ensure that only 
message and not potential genomic contamination was quantified, the primers were 
located in different exons, and the correct size of the product was verified through 
melting curve analysis after each run. Copy numbers were calculated for each sample by 
the instrument software using the second derivative maximum to determine the threshold 
fluorescence. Data were normalized against the static control for all time points prior to 
analysis.   
Collagenous protein accumulation. The amount of total collagen protein was 
determined by radio labeling all synthesized proteins with L-[2,3-3H]proline 
(PerkinElmer Life Sciences, Inc., Boston, MA) and by digesting collagenous proteins 
with collagenase (Sigma). MASMC were plated on the specimens in complete medium 
containing 3H–proline, which was changed every 24 hrs. After incubation, the proteins 
were extracted following a previously described method (Suh et al, 2001). To account for 
differences in cell proliferation, the data were normalized to DNA content. We measured 
DNA content by SYBR green (Molecular probes, Eugene, Oregon) nuclear staining with 
fluorescence quantitation in a micro-well plate reader (Perseptive Biosystems, 
Framingham, MA).   
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Collagen degradation assay. Collagen type 1 degradation by MMP-9 was 
investigated in cultures of WT or MMP-9 KO MASMC using fluorescently conjugated 
bovine skin type 1 collagen (Molecular Probes, Eugene OR). Cells were seeded in 24-
well plates with 10% FBS in DMEM for 24 hours. Fluorescein-conjugated type 1 
collagen was treated with serum free DMEM for 3 days. In some experiments, cultures 
were treated with 50 µM ethylenediaminetetraacetic acid (EDTA, Gibco, Grand Island, 
NY) for 3 days to inhibit MMP activity. Conditioned media were treated with 1:15 TCA 
at 4 oC for 20 min, then centrifuged at 1,500 g for 5 min at 4 oC. The supernatants were 
transferred to new 24-well plates, and the fluorescence intensity of degraded collagen 
was measured in a micro-well plate reader (Perseptive Biosystems) at 495 nm excitation 
and 515 nm emission.  
Polymer degradation assay. The polymer molecular weight distribution for the 
sample polymer discs was determined by gel permeation chromatography (GPC) (Perkin-
Elmer, Wellesley, MA) equipped with a refractive index detector (Perkin-Elmer). The 
dried samples were dissolved in tetrahydrofuran at a concentration of 8 mg/ml and eluted 
through the column at a flow rate of 1 ml/min at 37 °C. Polystyrene standards 
(Polysciences, Warrington, PA) were used to obtain a primary calibration curve. All 
samples of the same polymer type were analyzed in a single run. Variability in the 
determination polymer molecular weights by GPC for undegraded samples was about 1% 
relative standard deviation. 
Collagen fibrillogenesis assay. Investigation of the role of MMP-9 in collagen 
fibrillogenesis at the cell surface was performed using a previously described method 
with fluorescein-labeled collagen (Johnson and Galis, 2003). 
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In vivo host reaction to implanted scaffolds. Implanted PCL discs were harvested 
at 7 and 14 days post-implantation. The harvested discs were frozen-embedded with 
O.C.T compound (Tissue-Tek®, Sakura Finetek, Torrance, CA) in liquid nitrogen and 
sectioned using a cryostat (Leica, Nussloch, Germany). All cell nuclei were 
counterstained using hematoxylin. For detection of inflammatory cells, we performed 
Giemsa staining (Richard-Allan Scientific, Kalamazoo, MI) at 45 °C for 30 min, 
followed by differentiation in 1% acetic acid solution. In Giemsa staining, the cell nuclei 
stain purple, basophilic granules stain blue, and erythrocytes and eosinophilic granules 
stain pink to red. 
In vivo angiogenesis. We used a method developed for functional fluorescence 
microangiography to investigate angiogenesis into the implanted scaffolds at 7 and 14 
days post-implantation. Mice were sacrificed and perfused with 10ml heparinized saline 
(10 U/ml) injected through the left ventricle. Vessel capacity was determined using 0.1 
micron fluorospheres (Molecular Probes) at 1:20 dilution in heparinized saline. The 
scaffolds were harvested after perfusion and analyzed either by fluorescence phosphor-
imager (Amerhsam Bioscience, Piscataway, NJ) or by multi-photon fluorescence 
microscopy (Zeiss, Thornwood, NY). For imaging angiogenesis at the scaffold surface, 
the filter papers were detached, and the whole surface of the scaffolds was scanned to 
detect fluorescence-positive area. Detailed microvasculature could be visualized by 
multi-photon microscopy. For quantification of vessel capacity, the harvested scaffolds 
were incubated in xylenes at room temperature for 3 days to dissolve the perfused 
fluorospheres, and the relative fluorescence intensity was measured in a multi-well plate 
reader.  
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Statistical analysis. All data is shown as mean ± standard error with n=3 for each 
time point and each group. The paired student’s t-test was used to determine significance 
and a P value less than 0.05 was considered significant. 
 
4.4 Results  
Effect of MMP-9 deficiency on type 1 collagen mRNA production, protein 
accumulation and degradation by SMC cultured on TCPS.  Type 1 collagen mRNA 
production quantified by real time RT-PCR was not significantly different between WT 
and MMP-9 KO MAMSC on TCPS, for up to 14 days in culture. Collagen mRNA 
production increased up to 7 days, then decreased until 14 days in both WT and MMP-9 
KO MASMC in culture [Figure 6(a)]. Collagen protein accumulation in WT cultures was 
significantly lower than in MMP-9 KO cultures at 7 and 14 days post-seeding, suggesting 
degradation of collagen with presence of MMP-9. In comparison with 7 days, the 
difference of collagen accumulation between WT and MMP-9 KO was reduced at 14 
days [Figure 6(b)]. In experiments using fluorescently-conjugated type I collagen, MMP-
9 KO MASMC generated significantly less degraded collagen than WT, indicating that 
type 1 collagen was degraded by MMP-9 [Figure 6(c)]. Inhibition of MMPs by EDTA, a 
non-specific MMP inhibitor, significantly reduced type 1 collagen degradation in both 
WT and MMP-9 KO MASMC, but there was no significant difference between WT and 
MMP-9 KO. The intensity of the degraded fluorescent conjugate collagen value by WT 
without EDTA, was 1056.7 ± 4.9. The intensity of degradation by WT with EDTA and by 
MMP-9 KO without EDTA was 844.3 ± 3.8 and 970.7 ± 2.1 respectively. The calculated 
type 1 collagen degradation by MMP-9 was about 40.5%. The concentration of EDTA 
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was limited to 50 µM to avoid cytotoxicity (Kenney et al, 2003).  
Polymer degradation and collagen accumulation in the scaffolds.  Measurements 
of molecular weight distribution showed that there were no significant changes in polymer 
degradation between WT and MMP-9 KO mice, either in cultures of MASMC or after 
implantation in vivo up to 14 days [Figure 7(a), (b)]. This means that MMP-9 expressed either by 
MASMC or by other cells, in vivo did not degrade PCL scaffolds.  
Collagen protein accumulation by WT MASMC in the scaffolds was significantly 
lower than that of MMP-9 KO MASMC at 7 and 14 days post-seeding, which also 
suggested the selective degradation of collagen by MMP-9 [Figure 7(c)]. Collagen 
accumulation increased rapidly between 0 and 7 days, then began to level off between 7 
and 14 days in both WT and MMP-9 KO MASMC cultures, similar to the pattern 
observed on TCPS. 
Ascorbic acid treatment and collagen assembly.  To optimize the concentration of 
ascorbic acid, we evaluated type 1 collagen mRNA production at various concentrations. 
At 50 µM ascorbic acid, mRNA expression reached a maximum without any discernible 
cytotoxic effect (data not shown), in agreement with a previous study (Kurata and Hata, 
1991; Davidson et al, 1997). Ascorbic acid treatment improved type 1 collagen mRNA 
production in both WT and MMP-9 KO MASMC.  MMP-9 KO cells showed 625.7 ± 123 
% improvement compared to untreated controls, which was significantly higher than the 
189.9 ± 17.4 % increase in WT MASMC at 3 days. After 7 days of ascorbic acid 
treatment, however, collagen mRNA levels had fallen below those of untreated cells in 
both WT and MMP-9 KO cultures [Figure 8(a)]. Accumulation of collagen protein 
showed a different pattern from mRNA expression. Ascorbic acid treatment improved 
collagen protein accumulation 253 ± 6.4 % in MMP-9 KO MASMC compared to 
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untreated controls, which was also significantly higher than the 223 ± 8.2 % increase in 
WT cells at 3 days. However, at 7 days WT improved to 306.6 ± 14.3 % of untreated 
controls, which was significantly higher than the 274.9 ± 8.8 % elevation in MMP-9 KO 
MASMC [Figure 8(b)]. To evaluate cell-mediated collagen assembly, we compared WT 
and MMP-9 KO MASMC in a collagen fibrillogenesis assay with and without ascorbic 
acid. To account for differences in cell proliferation, the data were normalized to cell 
number. WT MASMC demonstrated significantly more fibrillogenesis than MMP-9 KO, 
as we reported previously.6 Ascorbic acid treatment improved collagen assembly 
significantly in both WT and MMP-9 KO, although WT showed significantly higher 
values than MMP-9 KO [Figure 8(c)]. Enhanced collagen assembly by WT MASMC 
might account for the observed difference in collagen accumulation compared to MMP-9 
KO at 7 days.  
In vivo host reaction to implanted scaffolds.  To obtain a measure of cell migration into 
the scaffold, we found that the cell density in the PCL scaffolds remaining undegraded at 14 days 
was greater in the WT than in the MMP-9 KO mice [Figure 9(a)]. To account for differences in 
PCL scaffold degradation rates, cell numbers were normalized to polymer area. We found that 
MMP-9 deficiency significantly impaired the total cell invasion of PCL scaffolds implanted in 
vivo at all time points [Figure 9(b)]. Migration of inflammatory cells followed a similar trend at 7 
and 14 days. We found that MMP-9 deficiency also significantly impaired inflammatory cell 
migration into PCL scaffolds in vivo at all time points [Figure 9(c)]. 
In vivo angiogenesis.  To quantify the extent of angiogenesis over the entire surface 
of the implanted scaffolds, we measured the fluorescence-positive surface area occupied 
by injected microspheres in PCL scaffolds harvested at 7 and 14 days after implantation 
[Figure 10(a)]. Quantification by image analysis showed that a larger area of fluorescence 
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due of perfusion of microspheres was detected in the WT than in the MMP-9 KO at 14 
days [Figure 10(b)]. To visualize the angiogenic microvasculature within the implanted 
PCL scaffolds, we performed optical sectioning with multi photon microscope and 3-D 
image reconstruction of the perfused vessels in scaffolds harvested at 7 and 14 days after 
implantation [Figure 10(c)]. Microvasculature in scaffolds implanted into WT mice was 
more highly developed than in those implanted into MMP-9 KO mice at both 7 and 14 
days. In WT mice, the microvasculature appeared to increase in extent and complexity 
from 7 to 14 days. Quantification of perfused vessel capacity using xylene extraction 
(Johnson and Sung et al, 2004) showed significantly more angiogenesis within PCL 
scaffolds harvested from WT mice than in those retrieved from MMP-9 KO mice at both 7 
and 14 days. These results support the hypothesis that angiogenesis was related to 
increased inflammatory cell invasion of scaffolds [Figure 10(d)].  In summary, MMP-9 
deficiency also impaired angiogenesis upon implantation of biodegradable scaffolds.  
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Figure 6.  Effect of MMP-9 on collagen production and degradation on TCPS. (a) Collagen type 
1 mRNA production was measured in cultures of WT and MMP-9 KO MAMSC using real time 
RT-PCR. The amplified copy number was normalized to 106 rRNA. (b) Collagen protein 
accumulation was measured in cultures of WT and MMP-9 KO MAMSC using a 3H-proline 
incorporation assay. The CPM value was normalized to DNA content to account for differences 
in cell proliferation rates. (c) Degraded collagen in medium of WT and MMP-9 KO MAMSC was 
measured using fluorescently conjugated type 1 collagen from bovine skin. 50 µM EDTA was 
used as a nonspecific MMP inhibitor. Collagen mRNA production and protein accumulation 
analyses were performed up to 14 days. The means obtained from 3 independent experiments ± 
SEM are shown. (*) P < 0.05 for WT vs. MMP-9 KO.   
                                           






































































































































































































Figure 7.  MMP-9 deficiency does not alter polymer degradation but increases collagen 
accumulation in PCL scaffolds. (a) In vitro degradation of the PCL scaffolds was measured in 
cultures of WT and MMP-9 KO MASMC or without cells as a control using GPC. (b) In vivo 
degradation of the PCL scaffolds was measured following subdermal implantation in WT or 
MMP-9 KO mice. (c) Collagen protein accumulation in the PCL scaffolds was measured in 
cultures of WT and MMP-9 KO MAMSC using a 3H-proline incorporation assay. The 
radioactivity in CPM was normalized to DNA content to account for differences in cell 
proliferation rate. All the experiments were performed up to 14 days. The means obtained from 3 
independent experiments ± SEM are shown. (*) P < 0.05 for WT vs. MMP-9 KO.   
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Figure 8.  Effects of ascorbic acid treatment on collagen production and assembly. (a) Type 1 
collagen mRNA production was measured in cultures of WT and MMP-9 KO MAMSC on TCPS 
with or without 50 µM ascorbic acid using real time RT-PCR. The amplified copy number was 
normalized to 106 rRNA. Data are presented as percentage of collagen production without 
ascorbic acid treatment. (b) Collagen protein accumulation was measured in cultures of WT and 
MMP-9 KO MAMSC on TCPS with or without ascorbic acid treatment using a 3H-proline 
incorporation assay. The CPM value was normalized to DNA content to account for differences 
in cell proliferation rate. Data are presented as a percentage of the production without ascorbic 
acid treatment. (c) Collagen assembly was measured in cultures of WT and MMP-9 KO MAMSC 
on TCPS with and without ascorbic acid using a fibrillogenesis assay. Data were normalized to 
cell number.  Collagen mRNA production and protein accumulation analyses were performed at 3 




                                           










































































































Figure 9.  In vivo host reaction to implanted scaffolds. Analysis of cell infiltration into PCL 
scaffolds implanted in WT (left panel) and MMP-9 KO (right panel) mice was performed at 0, 7, 
and 14 days using frozen sections. (a) Presence of cells is indicated by the purple nuclear staining. 
Inflammatory cells are detected by Giemsa staining (blue and pink staining). (b) Quantification of 
total cell density and (c) inflammatory cell density indicated a significantly increased cell 
invasion into the PCL scaffolds implanted in WT vs. MMP-9 KO mice. Error bars represent SEM 
for three separate implanted scaffolds (n=3). (*) P < 0.05 for WT vs. MMP-9 KO. 
 
 
                                           



















































































































Figure 10.  In vivo angiogenesis. Capillary formation in the PCL scaffolds implanted into WT 
(left panel) and MMP-9 KO (right panel) mice was assessed at 0, 7, and 14 days. (a) Fluorescence 
imaging was performed to determine the extent of angiogenesis on the surface of the scaffolds. 
(b) Angiogenesis was quantified by measuring the area of fluorescent bead perfusion into the 
scaffold (bright regions). (c) Multi-photon microscopic imaging was performed to visualize the 
capillary vasculature in the implanted scaffolds. (d) Functional vessel capacity was quantified by 
xylene extraction of perfused microspheres followed by fluorescence measurement. Error bars 
represent SEM for three separate implanted scaffolds (n=3). (*) P < 0.05 for WT vs. MMP-9 KO.  
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4.6 Discussion 
Degradation of extracellular matrix, most likely by matrix metalloproteinases 
(MMPs), has been thought to lead to mechanical failure of vascular constructs, 
suggesting that MMP inhibition might improve survival of constructs. However, our 
results support the idea that MMP-9 contributes to improving collagen organization. 
MMP-9 did not degrade PCL scaffolds in vitro or in vitro, but selectively 
degraded collagen in the scaffolds, which indicates that using biodegradable polymers as 
scaffolds can offer an alternative solution to prevent mechanical failure and preserve the 
beneficial effect of MMPs, especially MMP-9, upon the remodeling of collagen in the 
tissue engineered construct. 
Without ascorbic acid treatment, MMP-9 deficiency did not affect collagen 
mRNA production, but resulted in increased net collagen accumulation by MMP-9 KO 
than by WT cells, possibly due to impaired collagen degradation.  
In vitro collagen accumulation on TCPS at 14 days showed less difference 
between WT and MMP-9 KO than at 7 days, suggesting that improved collagen assembly 
such as fibrillogenesis in the presence of MMP-9 might affect long-term collagen 
accumulation. Upon treatment of ascorbic acid, collagen accumulation at 7 days in WT 
vs. MMP-9 KO, further supported the role of fibrillogenesis in collagen accumulation. 
Even though type 1 collagen mRNA expression was reduced by ascorbic acid treatment 
at 7 days, collagen protein accumulation was enhanced by ascorbic acid treatment at 7 
days than at 3 days, possibly due to collagen accumulation. Improving MMP-9-mediated 
collagen assembly by ascorbic acid treatment could provide a method to enhance the 
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remodeling process by synchronizing the degradation of the scaffold with growth of new 
ECM in tissue-engineered vascular constructs.   
Proteolytic degradation of ECM components is an essential component of cell 
invasion and angiogenesis. During these processes, MMPs seem to be primarily 
responsible for much of the ECM degradation (Shian et al, 2003; Jia et al, 2000). We 
found that cell migration into biodegradable scaffolds implanted in vivo was also 
dependent on MMP-9 activity. The infiltration of PCL scaffolds with host cells, 
specifically inflammatory cells, was found to be significantly lower in MMP-9 KO mice 
compared to WT animals, suggesting that MMP-9 deficiency prevented integration into 
the host vasculature. Thus, we suggest that MMP-9 mediates several functions important 
for the survival of thin scaffolds implanted in vivo. Interestingly, the degree of 
inflammation seemed to be related to the degree of angiogenesis, further demonstrating 
the biocompatibility of degradation products (Gough et al, 2003; Corden et al, 2000). 
Importantly, our results support the role of MMP-9 in eliciting an appropriate host 
inflammatory response in order to enhance the local recruitment of vasculature to tissue 
engineered constructs, essential for their integration as well as their long-term survival 
and function.   
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CHAPTER 5 
Combinatorial Screening of surface effects of biodegradable polymer blends for 
optimization of smooth muscle cell properties 
 
Sung H-J, Su J, Berglund JD, Russ BV, Meredith JC and Galis ZS. Manuscript in 
preparation.      
 
5.1 Abstract  
Controlling cellular and physiological responses such as adhesion, proliferation, 
and migration is a highly desirable feature of engineered “bioactive” scaffolds.  One 
important application would be the design of tissue engineered vascular grafts that 
regulate cell adhesion and growth.  We utilized temperature-composition combinatorial 
polymer libraries to investigate the effect of surfaces of blended poly D,L-lactic-glycolic 
acid (PLGA) and poly ε-caprolactone (PCL) on murine smooth muscle cells (SMC). In 
this manner, SMCs were exposed to ~1000 distinguishable surfaces in a single 
experiment, allowing the discovery of optimal polymer compositions and processing 
conditions.  SMC adhesion, aggregation, proliferation, and protein production were 
highest in regions with mid- to high-PCL concentrations and high annealing 
temperatures.  These regions exhibited increased surface roughness, reduced hardness, 
and decreased crystallinity relative to other library regions. This study revealed a 
previously unknown processing temperature and blending compositions for two well-
known polymers, which optimized SMC interactions.  
Key words: tissue engineering; combinatorial polymer libraries; annealing temperature; 
composition; surface properties; SMC interaction.   
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5.2 Introduction 
Synthetic biodegradable polymers have been used extensively for scaffold 
fabrication in tissue engineering applications because of their biocompatibility, 
degradation, and processability. However, actively controlling cellular responses such as 
adhesion, proliferation, and migration using “bioactive” surface features on the scaffolds 
(Meredith et al, 2003) remains an elusive goal that would greatly improve functionality. 
A fundamental challenge to this goal is the complexity introduced by combining 
materials science with biological science. Scaffold polymer surface chemical and 
physical (microstructural) properties can be adjusted in an almost infinite variety of 
combinations. When the complexity, uncertainty, and time-consuming aspects of cell 
culture and assays are added to the materials problem, conventional one-sample for one-
measurement approaches become overwhelmed (Chicurel, 2001; Brocchini et al, 1998). 
The result is that only a select few material surface chemical-physical property 
combinations are explored in a typical study, leading to a large unexplored variable 
“space.” 
To address this challenge, a method for culturing cells on combinatorial polymer 
libraries prepared using composition spread and temperature gradient techniques was 
recently presented (Meredith et al, 2003; Meredith and Smith et al, 2000; Meredith and 
Aims, 2000). This approach allows hundreds to thousands of distinct chemistries and 
microstructure properties on a single sample that could be evaluated simultaneously for 
bioactivity towards a given cell line. The combinatorial method reduces discovery time 
by orders of magnitude via high-throughput analysis of cell-polymer interactions. Truly 
“bioactive” scaffolds can be identified quickly (as well as nonfunctional compositions), 
                                           
                                                                                                                        
58
leaving more time and effort for a detailed examination of the mechanisms of the surface 
influence on cell behavior. 
One technique for generating surface diversity that has not been explored 
significantly in tissue engineering is phase-separation of polymer mixtures. The 
“demixing” of two polymers generates unique combinations of surface chemistry, 
microstructure, nanostructure, and roughness by adjusting annealing temperature and 
composition (Meredith and Aims, 2000). To investigate possible synergistic surface 
structures in a blend, we prepared temperature (T)-composition (φ) libraries of poly(D,L-
lactic-co-glycolic acid) (PLGA) and poly(ε-caprolactone (PCL)). While both polymers 
have been used extensively in implantable devices and tissue engineering, PLGA and 
PCL exhibit dissimilar properties including degradation rate, crystallinity, glass transition 
and melting temperatures, and mechanical characteristics (Supplemental Table 1) 
(Meredith and Aims, 2000; Lu and Peter et al, 2000; Lu and Garcia et al, 2000; Kweon et 
al, 2003; Schliecker et al, 2003; Lee et al 2003).  The effect of their blending on surface 
properties and cell responses has not been studied. The effects of PLGA/PCL mixtures on 
primary aortic SMCs cultured on the libraries were investigated using multiple analysis 
techniques for cell adhesion, proliferation, aggregation, and protein production. 
 
5.3 Materials and Methods 
Preparation of combinatorial chips. PLGA block copolymer (50:50 ratio of PGA 
and PLA; Mw = 40,000-75,000 Da) and PCL (Mw =114,000 Da) were obtained from 
commercial suppliers (Sigma Aldrich, St Louis, MO). Combinatorial chips consisted of 
polymer films (22x 22 mm) coated onto clean glass slides.  Annealing temperature (T, 
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oC) and concentration (φPCL, mass fraction) gradients were generated along orthogonal 
directions.  The composition gradient deposition process was applicable to a wide range 
of polymer blends and was described in detail elsewhere (Meredith et al, 2003; Meredith 
and Smith et al, 2000; Meredith and Aims, 2000).  Briefly, a PCL solution in CHCl3 
(Sigma) was pumped into a mixing vial initially containing a PLGA solution while the 
mixture was withdrawn, resulting in an increase in PCL composition in the vial.  A third 
automated syringe extracted the φPCL -gradient solution from the vial and deposited it as a 
thin stripe on the substrate. A knife-edge coater spread the liquid as a film orthogonal to 
the composition gradient. To explore a large processing T range, the φPCL -gradient films 
were annealed on a custom aluminum T-gradient heating stage for 2 hours, with the T-
gradient orthogonal to the φPCL -gradient. A heat source and heat sink produced linear 
gradients ranging between adjustable end-point temperatures (Meredith et al, 2003; 
Meredith and Smith et al, 2000; Meredith and Aims, 2000). Each library explored a wide 
range in processing T (50<T<120)°C, and composition (0.076 < φPCL < 0.375) mass 
fraction of PCL. Whole chip areas were divided to 9 regimes in the combination of 0.275 
< high φPCL < 0.375, 0.176 < mid φPCL < 0.275 and 0.076 < low φPCL < 0.176 with 96.6 < 
high T < 120 oC, 73.3 < mid T < 96.6 oC and 50 < low T < 73.3 oC for quantitative 
analysis. 
Cell harvesting and culturing. The Institutional Animal Care and Use Committee 
of Emory University approved all animal protocols used in this study. SMC were 
harvested from explanted aortas of C57BL6/J wild-type (WT) mice (Jackson 
Laboratories, Bar Harbor, Maine) as previously described (Galis and Johnson et al, 
2002). SMC cultured in DMEM (Cellgro, Herndon, VA) supplemented with 10% FBS 
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(Sigma), l-glutamine (Cellgro), and penicillin/streptomycin (Cellgro) were used in 
passages 3 through 8. Cells were tested and found to be >95% positive using a mouse 
anti- -actin antibody (Sigma). SMC were seeded (5x105) onto combinatorial chips. 
Culture medium was changed twice weekly throughout the experiments.  
Cell population and adhesion assay. Area-dependent SMC population 
measurements were performed on chips cultured up to 7 days. For cell adhesion assay, 
SMC were seeded on the chips and incubated for 8 hours. Medium was agitated to 
remove non-adhered cells. After culturing or agitating, SMC were fixed in 10% formalin 
and stained with SYBRTM green (Molecular Probes, Eugene, Oregon). Cell growth 
pattern, population and adhesion were observed using light and fluorescence microscope 
(Zeiss, Thornwood, NY), taking 10 × 10 grid of images over each cultured library. 
Localized area-dependent cell population or number was measured in the fluorescence 
images. The whole chip surface was scanned using fluorescence phosphor-imager 
(Amerhsam Bioscience, Piscataway, NJ).  
To measure adhesion SMC population on the individual uniform scaffold, DNA 
content were measured by SYBRTM green (Molecular Probes, Eugene, Oregon) nuclear 
staining after agitating the non-adhered SMCs. Fluorescence intensity of SYBRTM green 
was measured for quantification in a micro-well plate reader (Perseptive Biosystems, 
Framingham, MA).  
Cell viability and proliferation assay.  SMC viability was determined by staining 
the combinatorial chips with 20 µM propidium iodide (PI) (Sigma) and SYBRTM green 
(Park et al, 2000) (Supplemental Figure 1). Cell proliferation was determined through 
BrdU incorporation and 3H-thymidine uptake. 15µ M BrdU (BD Biosciences 
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Pharmingen, San Diego, CA) was added to SMC culture medium 12 hours before testing. 
SMCs were fixed with paraformaldehyde, then immunostained with primary rat anti-
BrdU antibody (Abcam, Inc, Cambridge, MA) and secondary RRX goat anti–rat IgG 
antibody (Jackson ImmunoResearch Laboratories Inc, West Grove, PA). Nuclei counter 
staining was performed with Hoechst 33258 (Sigma) to visualize the total number of 
cells. Localized area-dependent nonviable cell or proliferating cell were observed using 
fluorescence microscope (Zeiss), taking 10 × 10 grid of images over each cultured library 
and counted in the fluorescence images (Lessner et al, 2002; Xi et al, 1997).  
For the proliferation assay on the individual uniform scaffolds, 1µCi of 3H-
thymidine (PerkinElmer Life Sciences, Inc., Boston, MA) was added to SMC culture 
medium 24 hours before testing. After incubation, the cultured SMCs were rinsed with 
PBS twice, lysed and characterized for 3H-thymidine incorporation (Zhang et al, 2003; 
Ruef et al, 1998). 
Protein accumulation and production assay. To investigate localized medium 
protein accumulation on the combinatorial chips, 600 µCi of 35S- methionine 
(PerkinElmer Life Sciences, Inc.) is treated every 24 hours up to 3 days without SMC 
seeding. To chase the localized protein production of SMC seeded on the combinatorial 
chips, 200 µCi of 35S- methionine is treated every 24 hours up to 7 days (Tnasey, 2002; 
Rechinger et al, 2000). Methionine and cysteine depleted 10% FBS DMEM was used to 
treat 35S- methionine. Medium protein accumulation and SMC protein production were 
visualized using phospho-fluorescence imager (Amerhsam Bioscience).  
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Polymer characterization.   
Crossed-polar optical microscopy. Macroscopic reconstruction of entire chip 
surfaces were obtained by crossed polar optical microscopy using a BX51 Microscope 
System (Olympus, Melville, NY) to identify regions of PLGA-PCL phase separation and 
to measure the diameters and the number of islands of the PCL-rich regions (Meredith et 
al, 2003).  
Atomic force microscopy (AFM). AFM measurements were performed using a 
TMX 1010 Stage Scanning Probe Microscope (ThermoMicroscopes, Sunnyvale, CA) 
operating in the air in contact mode (Meredith et al, 2003). The surface topography and 
Z-modulus of different locations on PLGA-PCL libraries was measured. The average 
surface roughness was calculated using arithmetic means of the deviation in height from 
the topology image mean values. The averaged height was determined from arithmetic 
means defined as the sum of all height values divided by the number of data points. Phase 
structures and harnesses were illustrated in Z-modulus pictures. 
X-ray photoelectron spectroscopy (XPS). Composition and annealing temperature 
dependent surface compositions were analyzed by XPS (Surface Science SSX-100 with 
small spot ESCA spectrometer, Charles Evans & Associates, Sunnyvale, CA) with 
monochromatic Al K-alpha X-ray source (1486.6eV) (Klee et al, 2003). Survey scan 
spectrums were taken and surface elemental stoichiometries were determined from peak-
area ratios (Niklason and Abbott et al, 2001).  
Differential scanning calorimetry (DSC). Thermal analysis of the polymers was 
carried out with DSC (Seiko Instruments Inc., Chiba Japan) to calculate the effects of 
composition and annealing temperature on polymer crystallinity (van Dijkhuizen-
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Radersma, 2003). Uniform homogenous samples (5-15 mg) were heated from -70 to 
200°C at a rate of 10°C/min. Crystallinity was determined by the heat required for 
melting (mJ/mg). 
Uniaxial mechanical analysis. Effects of φPCL on mechanical properties were 
assessed through uniaxial cyclic loading using a electromechanical testing system (DLL 
650R, Eden Prairie, MN). Uniform individual films (200 µm thick) were stretched to 
10% strain, allowed to recover for 2 min, and loaded again to 0.3N to failure. Linear 
(Young’s) moduli, maximum stresses, yield strains, and recovery percentages (working 
strains) were determined from the stress-strain curves (Supplemental Figure 2). 
Statistical analysis.  Analytical results are expressed as means ± SEM. 
Comparison of multiple sample groups were performed using Tukey’s protected t-tests in 
combination with analysis of variation (ANOVA). Comparisons of individual sample 
groups were performed using unpaired student t-test. For all statistics, P<0.05 was 
considered statistically significant. 
 
5.4 Results 
Characterization of phase-separated microstructures and physical properties.  
Crossed-polar optical microscope images [Figure 11(a)], reveal the diverse 
microstructures formed on T-φ gradient libraries as a result of PCL/PLGA phase 
separation and PCL crystallization (Meredith et al, 2003). The phase-separated 
microstructures had an amorphous PLGA-rich matrix containing dispersed 
semicrystalline PCL-rich regimes. Larger PCL regions with both semicontinuous and 
droplet morphologies were observed as φPCL increased, consistent with spinodal 
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decomposition and nucleation-growth mechanisms of phase separation (Meredith and 
Aims, 2000). The diameter, d, of PCL-rich regimes increased with φPCL but showed a 
smaller dependence on T [Figure11(b)]. Either nucleation and growth rates of these 
PLGA-PCL phase-separated microstructures did not change much with T, or the 
annealing was stopped at a point where late-stage growth (Ostwald-ripening) had 
“equalized” the microstructure sizes at various T values.  The diameters covered the 
ranges: 21.8 < d < 31.8 µm (high φPCL), 11.4 < d < 17.6 µm (mid φPCL) and 5.4 < d < 7.7 
µm (low φPCL). 
The average surface roughness [Figure 11(c)] was highest at the mid φPCL –mid 
T regime and the second highest at the high φPCL –mid T regime. The other regimes did 
not show significant roughness differences among them. 3D lateral force AFM images 
revealed clear height differences between amorphous PLGA (blue) and peaked 
semicrystalline PCL (white) [Figure 11(d)]. It shows that the highest height difference 
was at the mid φPCL –mid T regime, with a negative value at the high φPCL –mid T regime. 
Mid φPCL –mid T regions possessed more overall concaved geometry surface structures 
than the other regimes, which showed predominantly convex island structures. 
AFM Z-modulus analysis showed that the transition, or boundary, regions 
between PCL and PLGA exhibited intermediate hardness values between that of the hard 
crystallized PCL islands and softer PLGA matrix [Figure 14(b)]. DSC was used to 
investigate the thermal properties and crystallinity of each regime (Pyne et al, 2003; van 
Dijkhuizen-Radersma, 2003) [Figure 14(c)]. Individual uniform films were prepared at 
each of the high, medium, and low annealing T, φPCL conditions observed on the libraries.  
As expected, the overall crystallinity followed the PCL composition. The crystallinity at 
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high φPCL = 0.375 showed no significant dependence on the annealing temperature. At 
middle φPCL = 0.225, crystallinity decreased significantly as annealing T was raised to 85 
oC and again at 110 oC (P<0.001), compared to 50 oC.  However, at low φPCL = 0.076 the 
crystallinity increased significantly as annealing T was raised from 50 oC to 85 oC and 
110 oC, which was opposite of the pattern observed at mid φPCL.  It is clear from 
comparison of the AFM and DSC characterization that the relative area of hard domains 
(as qualitatively indicated by AFM) followed the overall crystallinity.  The mid φPCL – 
high T regimes showed: (1) decreased crystallinity and hardness relative to mid- and low-
T regions at mid φPCL, and (2) intermediate crystallinity and hardness relative to all other 
φPCL –high T regimes. 
SMC adhesion, population distribution, and viability.  SMC cultured directly on 
the libraries (postannealing) for 8 h showed the highest adhesion at mid φPCL –mid T 
conditions (adhesion > 15%, P < 0.05) relative to other chip regions (adhesion 8 to 10 %), 
which showed no significant differences among them [Figure 12(a)].  Adhesion in each 
T, φPCL region is represented as a percentage of total cells on the entire library.  SMC 
adhesion was strongly correlated with the average surface roughness and the direct height 
difference between crystallized PCL and amorphous PLGA structures.   
SMC showed a significant area-dependent cell population increase in the mid-to-
high φPCL and high T regions at day 7 in comparison with day 1 [Figure 12(b)]. This trend 
is apparent in both fluorescence microscopy of individual chip regions and whole-library 
phosophoimaging scans, indicated that specific polymeric properties in those regimes 
strongly influenced SMC interactions with the scaffolds (Zhang et al, 2004; Cheng Z and 
Teoh, 2004; Niklason and Abbott, 2001; Niklason and Gao, 1999; Prabhakar et al, 2003). 
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The quantified 7 day cultured SMC population was largest at the mid φPCL –high T 
regime and second largest at high φPCL –high T [Figure 13(a)]. The other regimes didn’t 
show any significant differences among them.   
SMC viability (propidium iodide) at days 1 and 7 showed a statistically 
significant (P < 0.05) increase with increasing φPCL (Supplemental Figure 1), for example 
from 70 % to 90 % at day 1. Like the PCL diameter, this trend depended very little on T 
and overall SMC viability was increased at 7 day compared with 1 day. Even without the 
T effect, the mechanical properties showed apparent changes with increasing φPCL in 
blending (Supplemental Figure 2).  
SMC proliferation.  At 1 day, mid φPCL –high T and high φPCL –high T regimes 
also showed the highest percentages of proliferating SMC [Figure 13(b)]. The other 
regimes didn’t show any significant differences in the proliferation. The 7-day 
proliferation data [Figure 13(c)] exhibited an increase in most regimes compared to day 
1. There was no significant difference in day 7 proliferation among the regimes with the 
exception of the low φPCL – low T regime, which showed significantly fewer proliferating 
SMCs. A strong linkage between 7 day population [Figure 13(a)] and 1 day proliferation 
[Figure 13(b)] was observed; however, the higher cell populations at mid φPCL – high T 
regimes than at high φPCL – high T regimes could not be explained by SMC proliferation 
alone. This observation suggests that other effects are involved in the population 
dependence on surface features. 
SMC aggregation related with surface hardness, and thermal analysis for 
crystallinity.   Shortly after cell seeding, SMCs were observed to aggregate prevalently in 
the boundary regions between crystallized PCL islands (white) and the PLGA matrix 
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(dark) [Figure 14(a)].  As the regime-dependent change of crystallinity showed [Figure 
14(c)], it appears that the high SMC population at the mid φPCL –high T regime correlates 
with crystalline surface hardness (Washburn et al 2004), supported by micrometer scale 
surface hardness characterization from Figures 14(a), (b). Based upon the AFM [Figure 
14(b)] and DSC [Figure 14(c)] data, this behavior suggests a correlation between the 
local aggregation of SMCs and the polymer surface hardness, crystallinity, and feature 
height. 
Surface-composition-dependent serum protein adsorption and SMC protein 
production.   Localized serum protein (from culture medium) accumulation was 
visualized using 35S- methionine at 3 days without SMC seeding [Figure 15(a)]. The dark 
regions, indicating protein accumulation in the phospho-scan images, predominantly 
occupied the mid φPCL = 0.225 to high φPCL = 0.375 regimes at all T. This accumulation 
extended slightly into the low φPCL = 0.15 – high T regime as well.  XPS surface 
composition analysis indicated that the polymer blend surfaces were comprised mainly of 
oxygen, carbon, and hydrogen [Figure 15(b)]. There were no surface composition 
changes following shifts in the annealing temperature. However, averaged carbon 
contents increased from 52.5 % at low φPCL = 0.076 to 70.5 % at mid φPCL = 0.225, and 
relative oxygen contents decreased.  Interestingly, there were no remarkable changes 
from φPCL = 0.225 to φPCL = 0.375.  These trends in the average surface % carbon content 
must be due to selective expression of certain molecular segments over others at the 
surface, since the bulk % carbon in the PCL and PLGA monomers are both 1/3. Hence, 
the bulk % carbon does not change with composition.  It is likely that methylene groups 
are predominant on the surface due to their lower surface energy contribution compared 
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to the ether and carbonyl moieties. So, differences in % surface carbon probably derive 
from the different fractions of PCL-rich versus PLGA-rich surface domains.  PCL-rich 
domains have more methylene groups that can be expressed on the surface, which would 
be in line with the XPS data.  Comparing the qualitative description of protein deposition 
with quantitative surface compositions indicates that serum protein accumulation 
coincides the increased hydrophobicity on the carbon rich surface regions of the library. 
Following SMC seeding, protein expression maps displayed different patterns [Figure 
15(c)].  Compared to the pattern of the serum protein accumulation, 1-day protein 
production showed aggregation in distinct spots predominantly at mid and high φPCL – 
high T regimes. This SMC protein production matched the patterns observed in 1-day 
SMC proliferation [Figure 13(b)]. By 3 days, the protein production maps expanded to 
include high φPCL - mid T and low T regimes.  The 7-day protein production maps 
eventually covered the entire library surface except for the low φPCL – low T regime.  
These patterns also correlated with the 7-day SMC proliferation [Figure 13(c)].  These 
results imply that SMC proliferation was likely based on protein production mediated 
interaction, more so than the serum-protein accumulation.  
Verification of combinatorial library SMC adhesion and proliferation data.  
Individual uniform films were investigated to verify SMC adhesion and proliferation 
findings. Figure 16(a) shows SMC adhesion was highest in φPCL = 0.225, T = 85 oC 
samples.  These conditions corresponded to the mid φPCL – mid T regions of the 
combinatorial chips and matched the previous findings [Figure 12(a)].  Cell proliferation 
data [Figure 16(b)] also matched the combinatorial chip data [Figure 13(b), (c)]. The φPCL 
= 0.225, T = 110 oC samples showed significantly higher SMC proliferation than the 
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other samples at 1 day. The uniform samples at other T, φPCL didn’t show any significant 
difference among them. At 7 days, the φPCL = 0.225, T = 110 oC and φPCL = 0.225, T = 85 
oC samples and cover glass control showed a significant increase of SMC proliferation 
compared to their 1 day counterparts. Specifically, the φPCL = 0.225, T = 85 oC samples 
showed the most significant increases (P<0.001) at 7 days, which matched the 
combinatorial chip data.  At 7 days, the φPCL = 0.225, T = 110 oC and φPCL = 0.225, T = 85 
oC samples showed significantly higher cell proliferation rates than the other individual 
samples.  However, the φPCL = 0.375, T = 110 oC samples that represented the edge of the 
highest φPCL – high T in the combinatorial chip did not show any improvement of SMC 
proliferation.  All the individual film experiments verified the combinatorial chip findings 
and correlations among SMC adhesion and proliferation to the polymeric properties.   
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Figure 11.  Characterization of phase-separated microstructures and surface roughness. 
(a) Crossed-polar optical micrographs of selected regions from a PLGA/PCL T- φPCL 
library illustrate the diverse morphologies generated through the phase separation and 
crystallization.  White areas are crystalline PCL; dark areas are amorphous PLGA 
possibly containing some PCL.  The scale bar is 60 µm and the numbers in parentheses 
are (T, φPCL). (b) The diameter of PCL-rich regimes was measured using crossed-polar 
optical microscopy.  Means were obtained from 4 different spots at each regime for 3 
independent library chips. (c) Average surface roughness was obtained from arithmetic 
means of the deviation in height from the AFM topology image mean values. (d) Images 
(upper) from three-dimensional AFM lateral force represent the clear height difference 
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between two polymer domains. Averaged heights of both the polymer domains were 
calculated as arithmetic means from the sums of all height values divided by the number 
of data points. 
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Figure 12.  SMC adhesion and population distribution. (a) Adhered cell population was 
represented as a percentage of total SMC population on the whole chip. Means were obtained 
from 4 different spots at each 9 regime for 3 independent chip experiments. (*) P < 0.05. (b) SMC 
cultured directly on the libraries (postannealing) were visualized at 1 and 7 days with SYBRTM 
green nucleus staining in fluorescent micrographs and as black dots in the whole chip area scan 
images. Representative fluorescence and phospho scan images from three independent 
experiments are illustrated. 
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Figure 13.  Area-dependent SMC populations are linked to proliferation rates. (a) Each 
regime SMC population at 7 days is represented as a percentage of total SMC population 
on the whole chip. SMC proliferation rates were calculated as a percentage of BrdU 
positive cells at 1day (b) and 7 days (c). Means were obtained using 4 random spots in 
each of the 9 regions of 3 independent chip experiments. (*) P < 0.05.  
                                           
































































Figure 14.  SMC aggregation correlated with surface hardness and crystallinity. (a) 
Arrows show SMC aggregation around the boundary regions between the two polymer 
phases (10 × 10 grid of images). (b) AFM Z-modulus images represent surface hardness 
(100 X 100 µm size of images). Color changes from dark blue to light yellow represent 
increases in hardness. (c) Crystallinity was measured by DSC thermal analysis. Means 
were obtained from 3 independent experiments. (*) P < 0.05, (**) P<0.001 vs. at 50 oC 
annealing temperature. 
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Figure 15.  Surface composition dependent protein accumulation from culture medium 
and SMC protein production. (a) The dark areas indicate the culture medium protein 
accumulation dominant area without SMC seeding at 3 days in phospho scan image of 
the whole chip. (b) Surface compositions were analyzed by XPS using individual uniform 
chips. Surface elemental stoichiometries were determined from peak-area ratios of survey 
scan spectrum. (c) Black dots indicate SMC protein productions as through 35S- 
methionine phospho scan images. 1day images for SMC cultured without 35S- methionine 
were taken as negative controls. Representative phospho scan images of three 
independent experiments are shown.   
                                           














































































































































Figure 16.  Verification of combinatorial libraries SMC adhesion and proliferation using 
individual uniform films. The numbers in parentheses show (T, φPCL). The processing 
conditions (T, φPCL) were selected based on the combinatorial chip results. Glass 
coverslips were used as controls. (a) Fluorescence intensities of DNA labeled with 
SYBRTM green were measured to analyze SMC adhesion at 8 hours post seeding. (b) 
SMC proliferation was measured using 3H-thymidine incorporation at 1 and 7 days. 
Means were obtained from 3 independent experiments. (†) P<0.05 the adhesion or 
proliferation on the sample at the same evaluation time point or day vs. the other samples 
and (*) P < 0.05, (**) P<0.001 proliferation at 7day vs.1day. 
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Supplemental Table 1. 
PLGA (Poly lactic–co
–glycolic acid) PCL (Poly ε−caprolactone)
Structure
1-2X1062-5X105
Degradation 1- 4 months Over 1 year
Crystallinity Amorphous Semi-crystalline
Mw
Tg / Tm (oC) 55 / 200 - 60 / 60
Tensile Modulus
(GPa) 8.6 0.15




CH2 C   O
O
m




Comparison of the properties between PLGA and PCL used in this study. 
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Supplemental Figure 1.  SMC viability decreased at high PLGA compositions. (a) 1 day 
and (b) 7 day viability was measured by counting the percentage of cells that took up 
propidium iodide (PI) in each regime.  Means were obtained from 4 spots at each regime 
in 3 independent chip experiments. (*) P < 0.05 vs. the high φPCL at the corresponding 
temperature.  
                                           












































































































































Supplemental Figure 2.  Mechanical properties of blended PLGA/PCL were dependent 
on ΦPCL . (a) Maximum stress, (b) Linear (Young’s) modulus, (c) Strain at yield point 
and (d) Recovery percentage (working strain) were determined from stress-strain curves 
of uniformly fabricated polymer films; mass fraction (mf). (n=3)
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Supplemental Figure 3.  Crossed-polar optical microscopy reveals changes in crystalline 
microstructure following SMC culture.  (a) Number of PCL-rich islands. Means were 
obtained from 4 different spots at each regime for 3 independent chip experiments. Chip 
surfaces were compared (b) before cell seeding and (c) after 14 days of SMC culture. 
Scale bar represents 60 μm and the numbers in parentheses are (T (oC), φPCL). 
                                           












Supplemental Figure 4.  After 14 days of culture, SMC populations on the 
combinatorial chip coincided with areas of high protein production. (a) Area-dependent 
SMC populations were visualized at 14 days using SYBR green nuclei labeling and 
reconstructed using representative fluorescence images. (b) Phospho-scan images of 
entire chips show regions of 35S-methionine labeled protein production (black dots) after 
14 days of SMC culture. Arrows indicate the orientation of T and ΦPCL gradients.
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5.6 Discussion 
The combinatorial polymer libraries provided a high-throughput technique to 
investigate the effects of varying polymer properties on SMC interactions in a rapid, 
efficient, and accurate manner. In particular, the method provided rapid identification of 
blended polymeric properties that promote (or reduce) cell adhesion and proliferation for 
discovery of a truly “bioactive” scaffold.  Moreover, the high-throughput libraries 
identify quickly the major trends, so that more careful and detailed experiments can be 
performed afterwards to investigate fundamental mechanisms underlying the behavior.  
In this way, the most expensive and time-consuming assays can be focused onto the 
regions of composition and surface structure that are already known to yield the most 
information.  In this manner, the combinatorial assay technique couples nicely with 
traditional cell culture techniques. 
Previous studies have indicated the strong influence of surface roughness on cell 
interactions (Bagno A et al, 2004; Thapa et al, 2004; Miller et al, 2004), observed also in 
this study in terms of the direct height difference between crystallized and amorphous 
structures, and the averaged surface roughness [Figure 12].  
A strong correlation between SMC population and proliferation was shown in this 
study. However, the higher cell populations were observed at mid φPCL –high T regimes 
at 7 days, even though the mid- and high-PCL – high T regimes showed no significant 
differences in proliferation rate [Figure 13]. From the DSC thermal analysis [Figure 
14(c)], the decreased crystallinity in mid φPCL –high T regime was observed compared to 
the same or higher φPCL. Supplemental Figure 3(a) shows the area-dependent change in 
the number of crystalline islands and especially small number at mid φPCL –high T 
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regimes compared to the same φPCL, regimes, which also likely implied the effects of high 
T on crystallinity in mid φPCL. This suggested that the SMC aggregation might be caused 
by the surface hardness changes relating with crystallinity like osteoblast (Zhang et al, 
2004; ter Brugge et al, 2003; Yang et al, 2003). The strong possibilities between SMC 
aggregation and the surface hardness were shown in the micro scale investigation during 
initial culture periods [Figure 14(a),(b)], which could support furthermore the macro-
scale SMC aggregation across the each regime.  
An analysis of protein accumulation and surface composition showed that protein 
accumulation from the culture medium occurred predominantly at the hydrophobic 
carbon-rich surface regions (Collier et al 1997) [Figure 15(a), (b)]. This indicated the 
additional importance of the surface properties on biological interactions with scaffolds. 
Annealing temperatures did not affect protein accumulation from the culture medium, 
however, culturing SMC showed temperature dependent differences on SMC protein 
production [Figure 15(c)]. The importance of serum protein including fibronectin 
absorption on the cell adhesion on the matrix has been previously described (El-Ghannam 
et al, 1999), however, our study provided another possibility that the initial SMC 
interaction can be affected by the direct cell contact with the surface properties of the 
polymer scaffolds (Gugala and Gogolewski, 2004; Itala et al 2002), because the high 
SMC adhesion and 1-day high cell proliferation regimes were different from the high 
culture medium protein accumulation regimes. Supplemental Figure 3(b),(c) showed, 
even after 14 days culturing, there was no significant change in overall surface crystalline 
micro-structure, but 14-day localized cell populations were different from their 1- and 7-
day counterparts [Figure 11(c)], which indicated the direct cell contact with the surface 
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properties is not enough to explain long-term SMC interaction. Since strong correlations 
were observed between the high SMC proliferation regimes and the high SMC protein 
production regimes, it can be strongly suggested that even if the initial culture period 
SMC interactions can be affected by the direct cell contact with the surface properties, 
SMC proliferations are likely stimulated more through SMC protein production-mediated 
interactions. Supplemental Figure 4 supports this suggestion furthermore by showing the 
matched patterns between 14-day localized SMC population and protein production map.  
Literature evidence also shows that polymer surface chemistry, microstructure, 
and roughness influence cell adhesion, proliferation, and differentiation (Meredith et al, 
2003; Zhang et al, 2004; Cheng and Teoh, 2004; Niklason and Abbott et al, 2001; Bagno 
et al, 2004; Yang et la, 2003; Huang and Ingber, 2000; Wieland et al 2002). Future 
experiments, however, will be required to elucidate the potential issues regarding the 
effects of polymer properties, protein accumulation, and production (Collier et al, 1997; 
El-Ghannam et al, 1999; Gugala and Gogolewski, 2004; Itala et al, 2002; Boyan et al, 
1998; García et al, 1999) on SMC proliferation, migration, and adhesion relating with 
intracellular signaling.   
The individual film experiments verified the combinatorial chip findings that 
correlated SMC adhesion and proliferation to the polymeric properties. All these studies 
revealed a previously unknown processing temperature and blending compositions for 
two well-known polymers, which optimized SMC interactions.  
                                           







This study showed that 3D biodegradable scaffolds can be developed using a new 
method to control the thickness and pore size employing a knife-edge coater with a 
computer-controlled motion stage and phase-transitional salts. The comparative study of 
fast vs. slow degrading 3D scaffolds indicated that fast degradation negatively affects cell 
viability and migration into the scaffold in vitro and in vivo. This effect is likely due to 
the significant acidification of the local environment due to the polymer degradation. It is 
also reported that the angiogenic response developed within the scaffolds implanted in 
vivo was related to the presence of an inflammatory response. These results should 
contribute to a better understanding of the cell-biodegradable scaffold interactions 
necessary to optimize the manufacturing and survival of tissue constructs. 
The study of the function of MMP-9 on cell-matrix interactions for function and 
survival of vascular constructs showed MMP-9 deficiency did not affect collagen mRNA 
production or biodegradable polymer scaffold degradation, but net collagen accumulation 
was greater in cultures of MMP-9 KO than in WT SMC, because of degradation by 
MMP-9. Ascorbic acid treatment enhanced collagen deposition by MMP-9 KO compared 
to WT SMC at 3 days, but at 7 days this effect was reversed. MMP-9 improved 
fibrillogenesis of collagen, significantly more upon ascorbic acid treatment. •This study 
showed that MMP-9 deficiency led to a dramatic decrease in inflammatory cell invasion 
and capillary formation within biodegradable polymer scaffolds in vivo. Importantly, 
these results support the role of MMP-9 in eliciting an appropriate host inflammatory 
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response in order to enhance the local recruitment of vasculature to tissue engineered 
constructs, essential for their integration as well as their long-term survival and function.  
Overall, it could be concluded that inhibition of MMP-9 may negatively affect 
remodeling of collagen on scaffolds and decrease survival of implants by decreasing 
angiogenesis.  
Temperature-composition combinatorial polymer libraries were utilized to 
investigate the effect of surfaces of blended PLGA and PCL on MASMC to optimize 
polymer compositions and processing conditions for “bioactive” scaffold. These libraries 
tested the diverse distinguishable surface properties possible in a single experiment, such 
as phase-separated microstructures, roughness, hardness, and crystallinity. SMC adhesion 
was strongly correlated with the average surface roughness and the direct height 
difference between crystallized PCL and amorphous PLGA structures. SMC behavior on 
the libraries suggests a correlation between the local aggregation of SMCs and the 
polymer surface hardness, crystallinity, and feature height. SMC proliferation was likely 
based on protein production mediated interaction, more so than the serum-protein 
accumulation. The individual film experiments verified the combinatorial chip findings 
that correlated SMC adhesion and proliferation to the polymeric properties. All these 
studies revealed a previously unknown processing temperature and blending 
compositions for two well-known polymers, which optimized SMC interactions.  
MMP-9 was crucial for the remodeling process and angiogenesis required for the 
function and survival of the tissue substrates. These studies showed the importance of 
understanding effects of scaffold degradation rate on 3D cell growth and angiogenesis. 
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The novel combinatorial polymer blending method was suggested for applying “bioactive 
scaffold by determining the ideal biodegradable polymer processing conditions. 
                                           







Further investigations about the negative effect of lowering local pH caused by 
fast degradation, is necessary to verify the effect of different serum protein deposition 
between hydrophobic (PCL) and hydrophilic (PLGA) surfaces.  These could be 
performed by controlling the buffering effect of culture medium, then investigating the 
serum protein deposition effect on series in vitro and in vivo cellular viability or 
functional assay. 
In treatment of ascorbic acid, collagen type 1 mRNA expression was affected by 
MMP-9 deficiency. Ascorbic acid is a well-known reactive oxygen species  scavenger, so 
various future studies are possible to investigate the potential relationship between 
oxidative stress and MMP-9 from the view point of physiological or intracellular 
signaling pathways. 
Further detailed experiments will be required to elucidate the potential 
correlations regarding the effects of polymer properties of combinatorial libraries on the 
SMC adhesion, aggregation, and proliferation.  Also the further more experiments will be 
required to compare SMC interaction between the founded surface properties and tissue 
culture plates (TCPS). Interesting future studies that can be investigated specifically, are 
the effects of protein accumulation and production on SMC proliferation, migration, and 
adhesion relating with intracellular signaling.  In addition, the mechanical properties of the 
blended polymers vary as a function of PCL. However, potential further experiments are required 
to investigate the effect of annealing temperature and following surface structure change on the 
mechanical strength.  
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These studies may provide solutions for sourcing autologous tissue by applying 
this newly investigated cell scaffold interaction property to drive differentiation of stem 
cells to vascular cells, as well as developing 3D tissue engineered vascular constructs that 
can synchronize degradation time with remodeling of natural vascular tissue. Specifically 
in process of developing 3D tubular form of scaffolds, further detail considerations are 
necessary to maximize the benefit of blended polymer construct based on combinatorial 
chip findings.  
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